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Introduction  
 
1.1. Human embryonic stem cells (hESC)   
 
Embryonic stem cells (ES cells) were firstly derived 
independently from mouse embryos by two groups in 1981. These 
groups (Evans and Kaufman, 1981; Martin, 1981) demonstrated a new 
technique for culturing mouse embryos in the uterus, allowing for the 
derivation of ES cells from these embryos. Next, 1998 saw a 
breakthrough when James Thomson and collaborators (Thomson et al, 
1988) first developed a technique to isolate human embryonic stem 
cells (hESC) from the inner cell mass (ICM) of early-stage blastocyst 
embryos (5-8-day-old blastocysts), obtained from in vitro fertilized 
embryos (Fig.1). Cells were grown on irradiated mouse fibroblast 
feeder cells (MEF) in the presence of serum after adequate 
undifferentiated colonies were selected and propagated to new feeder 
cells in media containing serum replacement and bFGF (basic 
Fibroblast Growth Factor) (Thomson et al, 1998). Moreover, hESCs 
are pluripotent, are capable of differentiating into the three germ 
layers (ectoderm, mesoderm and endoderm) and can given rise to any 
cell type in the body, which is the most important difference that 
distinguishes them from endogenous adult stem cells (Thomson et al, 
1998). 
          Human ESC possesses two main characteristics: self-renewing 
and pluripotency (Fig.2). These cells express transcription factors 
(OCT4 and NANOG) and specific embryonic antigens 3 and 4 
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(SSEA3/4), high molecular weight glycoproteins, such as TRA-1-60, 
TRA-1-81,  and typical pluripotent markers, such as high telomerase 
and alkaline phosphatase activity, which are able to indefinitely divide 
in culture (Thomson J et al, 2000, Itzkovitz-Eldor J. et al, 2002).   
  
                  
Fig.1. Human embryonic stem cells derivation from the inner cell 
mass 
    Another feature of hESC is their ability to maintain 
karyotype stability with the XX and XY chromosomes. This 
characteristic is common with karyotypes of other species, but differs 
from lines of carcinogenic stem cells, which implies their genomic 
inestability (Thomson et al, 1998). Nevertheless, some reports 
demonstrated that hESC may have certain level of aneuploidy 
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(Carpenter et al, 2004), trisomy of chromosome 20 (Rosler et al, 2004) 
or an aberrant X chromosome (Inzunza et al, 2004). 
        
              
 
 
 
 
 
 
 
 
Figure.2. Pluripotent and self-renewing stem cell. One pluripotent 
stem cell is a potential source of different cell types. 
 
Another feature of hESC is the teratoma formation, which 
represents a tumor with all three germ layers after their introduction 
into immune deficiency mice (SCID) (Thomson et al, 1998). Indeed, 
as comented above, hESCs are pluripotent and capable of 
differentiating into the three germ layers (ectoderm, mesoderm and 
endoderm) and can given rise to any cell type in the body, which is the 
most important difference that distinguishes them from endogenous 
adult stem cells (Thomson et al, 1998). These properties of ESC are a 
critical process because they could cause teratoma formation in vivo. 
This is the reason why a well-defined protocol with tissue-specific 
progenitor cells is very important to avoid in vivo side effects.  
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Fig.3. iPSC reprogramming scheme. iPSCs are derived from adult 
cells by introducing reprogramming factors which are crucial for the 
induction of pluripotency and the self-renewing property. Cells could 
be differentiated to the mesodermal, endodermal and ectodermal 
lines, including all types of characteristic cells for each germ layer. 
 
  More recently, induced pluripotent stem cells (iPSC) (Fig.3) 
were described for the first time by Takashy and Yamanaka (2006). 
These cells were obtained by introducing four factors inducing the 
pluripotency state: Oct3 /4,Sox2, c-Myc and Klf4. In addition, iPS 
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cells have been derived by the introduction of Oct4, Sox2, Nanog and 
Lin28 (Thomson JA , 2007).  
It has been demonstrated that iPSC are very similar to 
embryonic stem cells and can be generated by the delivery of three 
genes (Oct4, Sox2, and Klf4) to differentiated cells (Yamanaka et al, 
2006) (Fig.3). The delivery of these genes "reprogrammes" 
differentiated cells into pluripotent stem cells, allowing the generation 
of pluripotent stem cells without the embryo. Since ethical concerns 
about embryonic stem cells are typically about their derivation from 
terminated embryos, it is believed that reprogramming to the iPS may 
prove less controversial.Human and mouse cells can be reprogrammed 
by this methodology to generate both human pluripotent stem cells 
and mouse pluripotent stem cells without an embryo. iPSC express 
cell surface markers, normal karyotypes, high telomerase activity and 
the potential to differentiate into all three germ layers (ectoderm, 
mesoderm and endoderm) showing human embryonic stem cells 
(hESC). Therefore, iPSCs are challenge in developing new approaches 
to define various mechanisms in different processes and cell 
replacement therapy, thus eliminating the controversial and ethical  
hESC-based issues (Somoza RA, Gallego Rubio FJ, 2012) ( Fig.3). 
 
1.2 Early Human Brain development and neural 
induction.  The human brain begins to form very early in prenatal 
life (just three weeks after conception) (Figs. 4 and 5). The nervous 
stem derives from the ectoderm, the outermost tissue layer, of the 
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embryo. derives from the ectoderm, the outermost tissue layer, of the 
embryo. During the third week of development, the neuroectoderm 
appears and forms the neural plate along the dorsal side of the 
embryo. This neural plate is the source of the majority of all neurons 
and glial cells in the mature human. A groove forms in the neural plate 
and, by week four of development, the neural plate wraps itself on it 
to make a hollow neural tube (Fig.5) The most anterior part of the 
neural tube is called the telencephalon, which expands rapidly due to 
cell proliferation, and eventually gives rise to the brain (Fig. 5). 
Gradually some cells stop dividing and differentiate into neurons and 
glial cells, which are the main cellular components of the brain. 
Newly generated neurons migrate to different parts of the developing 
brain to self-organise into different brain structures. Once the neurons 
have reached their regional positions, they extend axons and dendrites, 
which allow them to communicate with other neurons via synapses. 
Synaptic communication between neurons leads to the establishment 
of functional neural circuits that mediate sensory and motor 
processing, and underlie behavior.The human brain undergoes most of 
its development in the first 20-23 years of life Complex interactions 
among genetic, epigenetic, environmental and diffusible factors play 
critical roles in the developing brain (Purves, Neuroscience). For 
instance, during early embryonic development, the ectoderm becomes 
specified to give rise to the epidermis (skin) and the neural plate.  
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Fig.4. In vivo human development. Dr Mark Hill’s Cell Biology lab, 
School of Medical Sciences (Anatomy) 
  
The conversion of the undifferentiated ectoderm into the 
neuroectoderm requires signals from the mesoderm. At the onset of 
gastrulation, mesodermal cells move through the dorsal blastopore lip 
and form a layer between the endoderm and the ectoderm. These 
mesodermal cells, which migrate along the dorsal midline, give rise to 
a structure called the notochord The ectodermal cells overlying the 
notochord develop into the neural plate in response to a diffusible 
signal produced by the notochord. The ability of the mesoderm to 
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convert the overlying ectoderm into neural tissue is called Neural 
Induction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5. Neurulation in the mammalian embryo. On the left, we can see 
the dorsal views of the embryo at several different stages of early 
development (Purves, Neuroscience)       
 
At the molecular level, different signaling pathways, 
transcription factors and diffusible growth factors (e.g., sonic 
hedgehog, RA, FGF, BMP, Wnt) (Fig.6) participate in many specific 
processes during neural development. For example, the dorsal neural 
tube is patterned by BMPs (bone morphogenetic proteins) from the 
epidermal ectoderm flanking the neural plate.  These induce sensory 
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interneurones by activating Sr/Thr kinases and by altering SMAD 
transcription factor levels (Wilson and Stice, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6. Different signaling pathways during mammalian 
development ligands, receptors, downstream molecules; SHH (sonic 
hedgehog), RA (retinoic acid), FGF (fibroblast growth factor), BMP 
and Wnt (Purves  Neuroscience)       
 Likewise, the signals controlling anteroposterior neural 
development include FGF (fibroblast growth factor) and retinoic acid, 
which act in the hindbrain and spinal cord.   
Another example is Shh, which acts as a morphogen, and 
induces cell differentiation that is dependent on its concentration. At 
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low concentrations it forms ventral interneurones, at higher 
concentrations, it induces motor neuron development, while it induces 
floor plate differentiation at the highest concentrations. Failure of Shh-
modulated differentiation causes holoprosencephaly (Fig.6). These 
results indicate that the extrinsic (secreted or transmembrane) 
molecules released by sourounding cells and/or intrinsic signals 
produced inside the cell are required for the correct patterning of the 
nervous system during embryogenesis and neurogenesis.  
1.3. In vitro differentiation of human neural cells 
 As mentioned above, during organogenesis, neurulation or 
neural tube formation is one of the first processes to occur during the 
initial nervous system configuration (Itskovitz-Eldor et al, 2000). The 
hESC deriving from the inner cell mass of the blastocyst can be 
differentiated into embryonic bodies (EBs), which resemble the early 
post-implantation embryo (a blastocyst containing all three germ 
layers) (O'Shea, 1999). Indeed, the EBs (Fig.7) formed from hESC 
express different markers of germ layers, such as ζ-globin, 
representing mesoderm layers: α-fetoprotein for the endoderm and 
neurofilament 68Kd for the ectoderm (Itskovitz-Eldor et al, 2000).  
 
hESC can also be differentiated into columnar 
neuroectodermal cells called neural rosettes, and can mimic in vivo 
neuroectodermal development in terms of timing and morphology (Li 
and Zhang, 2006). In vitro, hESC differentiate into primitive 
neuroectodermal (or neural precursor) cells at around day 10.Then the 
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neuroectodermal cells exhibit neural tube-like rosettes in 14-17 days 
of differentiation in a chemically defined neural induction media 
(Gallego et al, 2010; Zhang et al, 2001). 
 
 
 
 
 
 
 
 
 
                 Figure.7. Embryoid bodies (Microscope Zeiss, CIPF) 
 
Neural rosettes (Fig.8) contain neural progenitors (NPs) cells, 
which are a starting point to more restricted progenitors, leading to 
neuronal and glial cell lines (Elkabetz  et al, 2008; Zhang et al, 2001). 
Proliferating NPs express high levels of Pax6, which is a 
neuroepithelial marker, as well as nestin, Sox2 and the homogenous 
expression of Sox1. Sox2 is a transcription factor regulating neural 
progenitor identity, which inhibits progenitor cells to reach a mature 
state, but provides proliferation of immature cells and maintenance of 
the progenitor pool of pro-neural cells. Inhibition of Sox2 restricts the 
proliferation of progenitor cells and the induction of neuronal and glial 
differentiation (Graham V, 2003).  
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In addition, NPs’ proliferating cells have been confirmed to 
express high levels of telomerase as their potential for stem cell 
maintenance and markers of NPs are Nestin, SOX3, MUSASHI-1 
(Stice S et al, 2008). Gene expression analyses have demonstrated 
induction of the expression of hESC markers during neural progenitor 
identity, such as a decrease of Nanog, and that the genes 
characterizing the early neural stage are in progression. 
 
 
 
 
Fig.8. The scheme demonstrates the neural induction process of 
human embryonic stem cells (hESC) passing through the inductive 
phase, with tri-dimensional structures called rosettes (agglomerates of 
neural progenitors-NPs) to propagated NPs  (Wilson and Stice, 2006). 
 
Moreover, one of the most important proteins for the tight 
junction of neuroepithelial cells is ZO-1 (which could be expressed in 
hESC), while the specific distribution of ZO-1 is a crucial point for 
neural induction. Besides, N cadherin (N-cad) and CD133, together 
with the aforementioned ZO-1, contribute to the neural induction 
process (Elkabetz, 2008). It is important to emphasize that the 
differentiation potential of rosette cells diminishes with proliferation; 
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this also occurs in vivo during neural development and with neural 
precursors in neural tube formation (Jessell, 2000). 
 
In short, the results of the derivation of neuroprogenitors from 
hESC provide an appropriate in vitro model to study early stages of 
the developing brain.     
 
1.4. Ethanol as a teratogen agent: Foetal Alcohol 
Syndrome (FAS) 
 
1.4.1. FAS and FASD in human studies 
 
 Ethanol is a well-recognised teratogen, and defects found in 
the children of mothers who consumed alcohol during pregnancy are 
one important brain developmental disorder. Indeed, ethanol is 
considered to be one of the most common substances that impact the 
developing brain, and prenatal alcohol exposure is a leading 
preventable cause of birth defects, mental retardation and 
neurodevelopmental disorders (American Academy of Pediatrics, 
2000). 
 
Among the most recognised consequences of prenatal alcohol 
exposure is foetal alcohol syndrome (FAS; Jones and Smith, 1973), 
characterised by pre- and postnatal growth deficiencies, craniofacial 
anomalies (Fig. 8) and evidence of CNS dysfunction. FAS is now 
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recognised as an important cause of intellectual disabilities and 
behaviour problems in many countries (Streissguth et al, 1991; Alati 
et al, 2006; Autti-Rämö et al, 2006; Ceccanti et al, 2007; Spohr et al, 
2007). However, over the last 30 years, it has become clear that FAS 
is not the only outcome resulting from prenatal alcohol exposure. 
Indeed, the effects of prenatal alcohol exposure lie in a continuum of 
physical anomalies and behavioural and cognitive deficits. The term 
foetal alcohol spectrum disorders (FASD) has been adopted (Sokol et 
al, 2003) as a nondiagnostic umbrella term to describe this range of 
effects. Prevalence of FASD, which can be physical, mental or 
behavioural, is estimated to be ~1% of all births (May and Gossage, 
2001). 
  
However, not until recently has it been possible to evaluate the 
effects of ethanol on human brain structure and function in vivo. 
Novel neuroimaging techniques such as magnetic resonance imaging 
(MRI), functional MRI (fMRI), diffusion tensor imaging (DTI), 
magnetic resonance spectroscopy (MRS), positron emission 
tomography (PET) and single photon emission computed tomography 
(SPECT) have been employed on individuals with FASD to provide 
insights into the structural and functional alterations caused by 
prenatal ethanol exposure These studies have demonstrated that 
prenatal ethanol exposure reduces the overall volume in the cranial, 
cerebral and cerebellar vaults in FASD (Swayze II et al, 1997; 
Archibald et al, 2001; Sowell et al, 2002a; Autti-Rämö et al, 2002 
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       Fig.9. Discriminating associated facial features of the FAS 
syndrome. (P.D. Sampson et al, 1997) 
 
Human neuroimaging studies have also demonstrated that 
reduction on different brain areas is not uniform and that the parietal 
lobe (Archibald et al, 2001; Sowell et al, 2002a, 2002b), portions of 
the frontal lobe (Sowell et al, 2002a) and specific areas of the 
cerebellum (Sowell et al, 1996; Autti-Rämö et al, 2002; O’Hare et al, 
2005) appear to be especially sensitive to alcohol insult. Basic animal 
studies have also evidenced the vulnerability of the CNS to the effects 
of ethanol, revealing that effects are not uniform and that some brain 
areas or cell populations are more vulnerable than others (Guerri, 
1998, 2002). 
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1.4.2. Factors influencing the effects of prenatal ethanol exposure 
on the developing brain 
 
         Clinical data indicate considerable variability in the range and 
magnitude of prenatal ethanol-induced effects on brain abnormalities 
and behavioural outcomes. Several biological and environmental 
factors are known to influence the effects of ethanol on the developing 
brain, including alcohol dose and exposure pattern, developmental 
timing of exposure, genetic background of the mother and foetus, 
maternal nutrition, maternal age, socio-economic status and 
synergistic reactions with other drugs. Among these factors, the levels 
of alcohol reaching the foetal brain and exposure duration markedly 
influence the type and extent of damage (Maier et al, 1996). In 
addition, mother and foetus’ genetic background such as variations in 
ethanol metabolism, also influence the risk of ethanol-induced 
malformations in the foetus (Thomas et al, 1998).  
 
1.4.3. Critical periods of brain development and effects of ethanol 
 
        Clinical and experimental data demonstrate that the specific brain 
structure affected and the magnitude of damage are strongly 
influenced by the developmental timing of ethanol exposure. For 
example, facial dysmorphology, a salient feature of FAS (Jones and 
Smith, 1973), appears to arise only when high-peak blood alcohol 
levels occur during the embryonic stage of gastrulation (Sulik, 2005). 
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Mice exposed to ethanol on embryonic day 7 (E7) or E8 (Sulik, 2005) 
and macaques exposed to ethanol on E19 or E20 (Astley et al, 1999) 
exhibit FAS-associated facial dysmorphia. Exposure to alcohol during 
gastrulation also has a negative impact on the developing brain by 
reducing the neural progenitors pool (Rubert et al, 2006) and causing 
long-term effects not only on the forebrain (Ashwell and Zhang, 1996; 
Miller, 2007) but also on mature brainstem nuclei structures (Mooney 
and Miller, 2007). Human studies demonstrate that both binge 
drinking and chronic alcohol abuse during early stage human 
embryogenesis (corresponding to the third week of human gestation) 
are associated with a greater incidence of craniofacial defects and 
mental disabilities (Ernhart et al, 1987). Although embryogenesis is 
the main critical period for alcohol teratogenesis, alcohol can also 
affect other ontogenetic stages of brain development. For example, a 
second critical period is the stage of neuroepithelial cell proliferation 
and migration, which occurs in humans from 7 to 20 weeks of 
gestation (Suzuki, 2007) and from gestation day 12 (G12) to G20–21 
in rats. At this stage, most nervous system areas (except the 
cerebellum) begin to differentiate.  
 
Experimental studies report that ethanol exposure at this stage 
alters neuronal migration and affects the timing and pattern of cell 
generation by reducing the number of neurons and glial cells in the 
neocortex, the hippocampus and the sensory nucleus (Gressens et al, 
1992; Miller, 1995b; Valles et al, 1997; Rubert et al, 2006). 
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 Fig.10. Sensitive periods for alcohol toxicity during fetal 
development. Major congenital malformations are represented in red. 
Functional defects and minor congenital anomalies are depicted in 
yellow.  
As with other neurodevelopmental disorders (Suzuki, 2007), 
perturbation of neuroglial proliferation and migration by ethanol could 
cause long-term abnormalities in the cerebral cortex and in brain size, 
as noted in individuals with FAS and FASD (e.g, Archibald et al, 
2001; Sowell et al, 2001a, 2002a), and likely contribute to the 
cognitive defects observed in adults with FASD. Additionally, since 
formation of the corpus callosum (CC) and the glial midline starts at 
around 7 weeks in humans (Paul et al, 2007; Richards et al, 2004), 
exposure to alcohol at this stage might disrupt early events in callosal 
formation, and may later dysregulate axonal pruning, leading to 
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agenesis, hypoplasia or abnormalities in the CC (e.g., Riley et al, 
1995; Swayze II et al, 1997; Bhatara et al, 2002). In fact, 
administration of a single high dose of ethanol to neonatal rats 
markedly reduced the thickness of the CC (Olney, 2004), possibly 
resulting from loss of cerebro-cortical neurons whose axons 
projections comprise much of the CC mass. 
         
Finally, alcohol also interferes with the ‘brain growth spurt’ 
neonatal stage in the rat (roughly the equivalent of the third trimester 
of human gestation), a period characterised by glial development 
(astroglial and oligodendroglia), synaptogenesis and development of 
the cerebellum. Ethanol exposure induces microcephaly, causes 
neuronal cell loss in both the hippocampus and the cerebellum 
(Goodlett and Lundahl, 1996; Dikranian et al, 2005), alters 
synaptogenesis and glial development (Guerri and Renau-Piqueras, 
1997) and can cause learning/memory deficits, as well as long-term 
and neurobehavioural dysfunctions (Wozniak et al, 2004; Popovic et 
al, 2006). In addition, administration of a single high or moderate dose 
of ethanol to neonatal mice throughout the early synaptogenesis 
period triggers a significant neuroapoptosis in several brain regions 
(e.g., forebrain, midbrain, brainstem, cerebellum, spinal cord and 
retina) (Ikonomidou et al, 2000; Dikranian et al, 2005; Tenkova et al, 
2003), with the caudate nucleus and the frontal and parietal cortices 
being the most vulnerable regions to the neuroapoptotic effects of 
ethanol (Young and Olney, 2005). In line with these data, alterations 
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in the caudate nucleus and in the frontal cortices have also been noted 
in individuals with FASD (Cortese et al, 2006; Fagerlund et al, 2006). 
         
Collectively, experimental data indicate that although ethanol 
can interfere with important ontogenetic stages of the mammalian 
brain, the levels of ethanol reaching the foetal brain and the 
developmental timing of ethanol exposure, particularly early 
embryogenesis, are important determinants of the specific brain 
structures affected and the resulting degree of damage. 
 
1.4.4. Potential mechanisms involved in ethanol-induced brain 
damage during development 
 
Several molecular mechanisms have been identified as 
potential candidates responsible for the range of FASD phenotypes 
(Guerri 1998, 2002; Goodlett et al, 2005). These mechanisms are 
likely to participate at different stages of development and/or with 
different doses of ethanol. They include (1) alterations in the 
regulation of gene expression (e.g. reduced retinoic acid signalling, 
homeobox gene expression, altered DNA methylation; Deltour et al, 
1996; Rifas et al, 1997): (2) interference with the mitogenic and 
growth factor responses involved in neural stem cell proliferation, 
migration and differentiation (see revs., Mooney et al, 2006; 
Siegenthaler and Miller, 2006): (3) disturbances in molecules that 
mediate cell–cell interactions (L1, NCAM, loss of trophic support; 
e.g. Wilkemeyer et al., 2002; Miñana et al, 2000): (4) activation of 
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molecular signalling that controls cell survival or death (growth 
factors deprivation, oxidative stress, apoptotic signalling and caspase-
3 activation, suppression of NMDA glutamate and GABAA receptors, 
withdrawal-induced glutamatergic excitotoxicity, (e.g. Guerri et al, 
1994; Pascual et al, 2003; Olney, 2004; Young et al, 2005) and (5) 
derangements in glial proliferation, differentiation and functioning 
(Guerri et al, 2001, 2006). This last mechanism is supported by 
neuroimaging studies which reveal global white matter reductions and 
abnormalities in FASD (Archibald et al, 2001; Sowell et al, 2002a).  
Although several mechanisms have been postulated, we still do not 
know why exposure to alcohol during early embryogenesis results in 
the facial anomalies associated with FAS and causes mental 
retardation. 
   
1.5. TLR receptors  
Toll-like receptors (TLRs) are transmembrane pattern-
recognition receptors that initiate signals in response to diverse 
pathogen-associated molecular patterns (PAMPs). The first Toll 
protein was discovered in Drosophila melanogaster, where it 
controls dorso-ventral patterning. A mammalian homologue for Toll, 
TLR4, was later found to recognise bacterial lipopolysaccharide 
(LPS), a major cell wall component of gram-negative bacteria. 
Subsequently, many additional homologues have been identified 
across diverse species.  
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The TLRs family involves 13 members and they participate in 
the innate immune response. In addition to the pathogen-derived 
ligands that activate the different TLRs, endogenous TLR ligands 
referred to as damage- (or danger-) associated molecular patterns 
(DAMPs) have been identified. Numerous endogenous ligands have 
been described and include low molecular weight hyaluronic acid 
(LMW-HA), fibrinogen, fibronectin, β-defensins, heparin sulphate 
proteoglycans and heat-shock proteins (Kawai and Akira, 2006).  
         
 Recent findings suggest that mammalian TLRs play 
developmental roles during embryogenesis, as well as physiological 
and metabolic roles in adults. For example, TLR5-deficient mice 
exhibit hyperphagia and develop hallmark features of metabolic 
syndrome, including hyperlipidemia, hypertension, insulin resistance 
and increased adiposity. Likewise, TLR2 and TLR4 play an important 
role in the maintenance or proliferation and differentiation of Neural 
Progenitors Cells (NPC) directing self-renewal or cell fate decision. In 
vivo experiments also show that mice deficiency of TLR2 has 
negative impact on adult hippocampal neurogenesis whereas on the 
contrary, absence of TLR4 increases the proliferation rate and 
differentiation process (Okun et al, 2011).  
        
 Activation of a given TLR engages distinct signalling 
pathways in different neural cell types. For example, TLR4 activation 
results in distinct signalling outcomes in astrocytes, microglia, 
neurons and neural progenitor cells (NPCs), and these pathways differ 
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from TLR-induced signalling in dendritic cells (Fig 9). TLR4 
activation in dendritic cells signals through a myeloid differentiation 
primary response gene 88 (MyD88)-dependent pathway to activate the 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) 
and to produce cytokines such as tumor necrosis factor-α (TNF-α), 
interleukin 6 (IL-6) and IL-12. The MyD88-independent TRIF 
pathway is also activated and results in the nuclear translocation of 
Interferon regulatory factor (IRF)-3 and in the synthesis of interferon 
β (IFN-β), which then activates its receptor coupled with Signal 
Transducer and Activator of Transcription-1/2 (STAT-1/2) and IRF-9 
and with a secondary wave of transcription of cytokines and 
chemokines such as interferon gamma-induced protein 10 kDa (IP-10) 
and Glucocorticoid Attenuated Response Gene 16 (GARG16).  
         
 In astrocytes, however, TLR4 activates the MyD88- but not 
the TRIF-dependent pathway. In these cells, MyD88-mediated 
signaling leads to the NFκB-induced transcription of TNF-α, vascular 
cell adhesion molecule 1 (VCAM-1) and IL-27, whereas other 
signalling mediators such as c-Jun N-terminal kinases (JNK) activate 
STAT-1 to transcribe IP-10 and to suppress cytokine signalling 
proteins-1 (SOCS-1) 
 
Extracellular-signal-regulated kinases (ERK) are also activated 
by LPS in these cells independently of MyD88. TLR4 activation in 
microglia resembles its activation of dendritic cells, with both the 
MyD88- and TRIF-dependent signalling pathways in an active state. 
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These in turn induce NFκB activation which promotes the 
transcription of cytokines such as TNF-α, IL-6 and IL-1β, and IRF-3 
activation resulting in the IFN-β-mediated activation of STAT-1 and 
 
he TLRs, a type I integral membrane glycoproteins, are a member of a large superfamily that includes the interleukin-1 
receptors (IL-1Rs).TLRs and IL-1Rs have a conserved region of ~200 amino acids in their cytoplasmic tails, which is known 
as Toll/IL-1R (TIR) domain.
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Fig.11. Scheme representing Toll-like receptor signalling.  The ligand 
for TLR4 is LPS (lipopolysaccharide) endotoxin chemically identified 
and characterised in the most of Gram-negative bacteria and ethanol 
is also shown ethanol as a potential ligand for this receptor. A 
downstream pathway is also shown; MAP kinases the activation leads 
to activation of AP1 and NFkB transcription factors which induce 
genes that encode cytokines and inflammation- associated molecules. 
.  
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subsequently IRF-1(Kawai and Akira, 2006; Okun et al, 
2011)(Fig.10). 
         
Activation of TLRs causes neuroinflammation and TLRs are 
involved in the pathogenesis of stroke, Alzheimer’s disease (AD) and 
multiple sclerosis (MS) as well as other neurodegenerative diseases 
(Glass CK et al., Cell 2010). Notably, it has been demonstrated that 
ethanol induces TLR4 signaling neuroinflammation and brain damage 
when acting as a TLR4 agonist (Alfonso-Loeches et al, 2010). Recent 
findings suggest a new role of TLRs as modulators of CNS plasticity. 
TLRs influence neuroprogenitors proliferation, differentiation, neurite 
outgrowth and behavioural plasticity. 
 
However, although evidence from mice deficient in TLRs 
strongly implicates these receptors in neuroplasticity, the distinction 
between developmental and functional effects of the life-long 
deficiency of a TLR, as well as the specific roles of TLRs during 
ontogeny and in neuroplasticity following infection and injury remain 
unclear. 
  
 
1.6.Cannabinoid receptors (CBs) 
 
Since the identification of two cannabinoid (CB) receptors for 
the plants major active constituent ∆9-tetrahydrocannabinol (THC) 
around 1990, endogenous ligands, endocannabinoids, have been 
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discovered, and have led to the definition of the 'endocannabinoid-CB 
receptor (ECBR) system'. Ligands, including anandamide and 2-
arachidonylglycerol, are particularly interesting since they are 
derivatives of arachidonic acid, and they also interact with related 
lipids such as oleoylethanolamide 
  
 
 
 
 
 
 
         Fig.12. Scheme of cannabinnoid receptors CB1 and CB2  
.  
There are two main receptor types associated with the 
endocannabinoid signalling system: cannabinoid receptor 1 (CB1) and 
2 (CB2). Both receptors are 7-transmembrane G-protein coupled 
receptors (GPCRs), which inhibit the accumulation of cyclic 
adenosine monophosphate within cells. CB1 receptors are present at 
highest concentration in the brain, but can also be found in the 
periphery. CB2 receptors are mostly located in the immune and 
haematopoietic systems. The enzymes involved in endocannabinoids 
synthesis and degradation are NAPE-PLD (N-
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Acylphosphatidylethanolamine (NAPE)-hydrolyzing phospholipase 
D) and FAAH (fatty acid amide hydrolase), respectively. 
 More recent studies have demonstrated that endocannabinoid 
signalling controls neural progenitor differentiation in the mice adult 
brain by promoting astroglial differentiation of newly born cells. 
These results show a novel physiological role of endocannabinoids, 
which constitute a new family of signalling cues involved in the 
regulation of the neural progenitor cell function (Aguado T et al., 
2005, 2006). However, since all the studies done on the role of 
endocannabinoids have been preformed in mice, it is presently 
unknown whether endocannabinoids are expressed in human ESC, 
and whether they play a role in the proliferation and differentiation of 
human neuroprogenitors. 
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The main objectives of this work are to use neural human 
neuroprogenitor (NPs) cells from hESC as a tool to study the cellular 
and molecular events involved in early human neural development 
under physiological conditions and to study the teratogenic effects of 
ethanol during the initial formation of the CNS.  
 
Objectives 
 
 To develop an in vitro protocol of derivation of human neural 
progenitors (hNPs) from hESCs, which could mirror early 
stages of human brain development 
 
 To characterize the in vitro culture by evaluating the gene and 
protein expression of human Neuroprogenitors (hNPs) in 
culture during their proliferation and differentiation into 
mature cells (neurons, astrocytes and oligodendrocytes). 
 
 To assess whether the endocannabinoid system, including 
endocannabinoid receptors (CB1, CB2) and the enzymes 
involved in their synthesis (NAPE-PLD) and degradation 
(FAAH) of endocannabinoids (EC), are expressed in human 
neural progenitors during their differentiation to mature 
nervous cells. 
 
Objectives                                                               29 
 
 
 To assess the gene and protein expression of TLR4 and TLR2 
receptors during neural differentiation from hESC (in vitro) 
and during brain ontogeny in mice. 
 
 Finally, the last objective will investigate the actions of ethanol 
on the proliferation and differentiation of hNPs. Specifically 
we will assess the effects of different physiological 
concentrations of ethanol on: 1) gene and protein expressions 
during the derivation of hESC to NPs: 2) the proliferation and 
cells survival of the hNPs, 3) the NPs differentiation processes 
to mature neural cells, by assessing gene and protein 
expressions and morphological alterations.  
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Materials and Methods 
 
 
3.1. Human embryonic stem cells culture (hESC) 
Human embryonic stem cells (hESC) (H9 line, WiCell Inc., 
Madison WI) were grown in human embryonic stem cells medium 
(hES medium) cultured on commercially available human foreskin 
fibroblast-HFF (American Type Culture Collection, ATTC, Manassas, 
VA), MEF (CF-1 MEF, P3) and  STO line (CRL-1503TM  ATCC) and 
all of the fibroblast were inactivated with mitomycin C (Sigma ref: I 
3390). The hESCs were cultured in appropriate conditions in hoods 
with termal plates (37̊C), floating air, UV protection, incubator at 37̊C, 
5% CO2, in humidity. The hESC colonies were replated, according to 
their size at 6-7 days period, passaging small pieces by mechanical 
dissection (performed with the insulin needle). The colonies were 
cleaned mechanically from differentiated cells and medium was 
changed every second day. For the maintenance of hESC we used also 
mTeSRTM1 Medium kit (StemCell Technologies Ref: #29106) which 
containes mTeSRTM1 Basal Medium and mTeSRTM1 5X supplement. 
In addition, a conditional medium (CM) obtained from hESC cultured 
on human foreskin fibroblast-HFF feeders were also used. This CM 
contains grown factors and metabolites which were released by hESC 
in culture.  
 
 
Material and Methods                                                                          31 
 
 
3.2. Human foreskin fibroblast cell culture 
 
a)Inactivaton of human foreskin fibroblast (HFF) by mitomycin C 
Fibroblasts were inactivated with mitomycin C (Sigma ref: I 
3390) 10μgr/ml.  Mitomycin C was added to the flask with FSK 
medium (HFF medium; see bellow) for 2.5-3 hours (a 15 ml flask, we 
added 150μl of mitomycine C). After three hours, the medium with 
mitomycin C were aspirated from the flask and inactivated cells were 
washed 3 times with phosphate-buffered saline (PBS) without Ca2+ 
and Mg2+. 
Then, in order to detach inactivated fibroblasts, a TRIPLE 
SELECT reagent (Gibco 12563-011) was added to the flask. This 
reagent is animal origin-free cell dissociation enzyme which can be 
used instead of porcine trypsin. This step was performed at 37 º C for 
5 minutes in the incubator. Cells were then centrifuged at 1200rpm for 
3-5 min, the pellet was resuspended with complete fibroblast medium,  
cells were counted and plated (150.000-200.000 for 6-well plates) on 
the  Gelatin covered plates (Sigma ref: G1890)  
 
b) Fibroblast passaging 
Confluent fibroblasts were divided into 3-4 new flasks .For 
this, the FSK medium was removed, cells were washed three times 
with DPBS or Dulbecco’s Phosphate Buffered Saline not containing 
calcium, magnesium, and then 3 ml of TRIPLE SELECT (Gibco 
12563-011) were added in each 15 ml flask. After 3-5 min, the cells 
were removed and centrifugated at 12.000 rpm for 5 min. The cells 
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were the washed 2 times. The last pellet was resuspended in 9.5 ml of 
FSK medium, fibroblasts were divided into three or four P75 flasks 
and fresh medium was added to each flask. Flasks were kept in an 
incubator at 37 ºC, 5% CO2 in humidity conditions. The medium was 
changed every 3 to 4 days. 
 
FSK (Fibroblast medium) 
 ISCOVES Modified Dubelcco’s Medium (Sigma: I3390) 
 FBS (fetal bovine serum) Ref:  10091-148 Invitrogen (Gibco) 
 Glutamax Ref: 35050 Invitrogen (Gibco) 
 P-S (Penicillin/Streptomycin) Ref: 15070 Invitrogen (Gibco) 
 
c) Fibroblast freezing and thawing procedure 
For fibroblast freezing, the medium of the cells were aspirated 
and cells were washed once with PBS. Then, the cells were detached, 
by using Trypsin or TRIPLE SELECT for 3-5 minutes, and 
centrifuged at 300 rpm for 5 minutes. The supernatant was aspirated 
and the medium for cell freezing (SBF 90%, DMSO 10% (Sigma 
D2650) was added to the cells. The tube containing the cells was 
immersed directly into a freezing container (Mr Frosti) overnight and 
then the tubes were stored to -80 º C. 
For fibroblast thawing, vials containing the cells at -80ºC were 
thawed by immersion in 37º C water bath. Then, FSK medium was 
added drop by drop to the cell vial, mixed gently, transferred to the 15 
ml tube and centrifuged at 300 rpm for 5 minutes. The supernatant 
was aspirated and fresh FSK medium (1ml) was added.  
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3.3. Alkaline phosphatase staining procedure  
 Alkaline phosphatase is a stem cell membrane marker and 
elevated expression of this enzyme is associated with undifferentiated 
pluripotent stem cell. All primate pluripotent stem cells, like Embryonic 
stem (ES), embryonic germ (EG) and embryonic carcinoma (EC) cells, 
express alkaline phosphatase activity. For the detection and staining of 
hESC with of Alkaline phosphatase we used a kit provided by 
Chemicon(No 001). Briefly,  
1. Human embryonic stem cells, H9; were cultured for five days, at 
low density (Under our experimental conditions five days of culturing 
are optimal for good AP stain visualization). 
2.  On day five, the medium was aspirated and the hESC were fixed 
with 4% Paraformaldehyde in PBS for 1-2 minutes. 
3. The fixative was aspirated and rinsed with 1X Rinse Buffer, 
avoiding cell drying. 
4. The reagents were prepared for Alkaline Phosphatase staining.  
5. The stain solution was added to cover each well and incubated in 
the dark room temperature for 15 minutes. 
6. The staining solution was aspirated and rinsed wells with 1X PBS 
to prevent drying and then the number of AP expressing colonies were 
counted (red stem cells colonies), versus the number of different 
colonies (colourless). 
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3.4. Neural induction, neuroprogenitors proliferation and  
      differentiation. 
 Human embryonic stem cells, the H9 line were cultured on 
commercially available human foreskin fibroblast and cultured in 
hESC medium (see below) which contains basic Fibroblast Growth 
Factor, at 37C in 5% CO2 in a humidified atmosphere.  
 The hESC colonies were replated, according to their size, after 
a 6- to 7- day period, by passaging small pieces by mechanical 
dissection. To obtain embryonic bodies (EB), the hESC colonies were 
transferred to low attachment plates and maintained in the same 
medium for 6 days. 
 For neural induction, after six days in culture, EB were 
scattered and transferred to adherent conditions on Matrigel-coated 
plates and cultured with neural induction medium (NIM) . The cells 
from attached floating formations started to spread radially after 5 
days. Rosettes were cut and desegregated to obtain single cells which 
contain the neuroprogenitors (NPs). Cells were the plated on 
polyornithine/laminin plates (350,000 cells per 2ml plate) and cultured 
with neural proliferating medium (NPM). The NPs proliferated in the 
plates until they became confluent and according to their number, they 
were passaged into polyornithine-laminin plates with fresh NPM 
medium (NPM). On day 21 the NPM medium was replaced by a 
Neural Differentiating Medium (NDM) which contains BDNF. Cells 
were maintained for an additional 15 days in NDM (Nat et al. 2007). 
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hESC medium 
 DMEM Knockout (Gibco, Cat.No. 10829-018) 
 Serum Replacement (Gibco, Cat.No. 10828-028) 
 L-Glutamine 200 mM 
 P-S (Penicillin/Streptomycin) Ref: 15070 Invitrogen (Gibco) 
 MEM (Gibco Cat. No. 11140) 
 bFGF (Invitrogen Cat.No. PHG0263) 
 
Neural Induction Medium (NIM),  
 DMEM/F12 and Glutamax: Neurobasal (1:1), B27 supplement 
(Invitrogen), N2 supplement (Invitrogen), 2mM Glutamax 
(Invitrogen), Penicillin/Streptomycin. 
 
Neural proliferation medium  
bFGF (20ng/ml), DMEM/F12, Glutamax:Neurobasal (1:1), B27 
supplement, N2 supplement, 2mM Glutamax and 
Penicillin/Streptomycin 
 
Neural differentiation medium 
containing Neurobasal medium, B27 (Gibco, Invitrogen), 2mM 
Glutamax, Penicillin/Streptomicin, 10 ng/ml BDNF (Brain Derived 
Growth Factor, Invitrogenn Cat. No. 10908-010). 
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3.5. Cell Proliferation Assay 
For cell proliferation assay, BrdU incorporation was assessed 
using a commercial kit (Roche, cat no. 11810740001) and was 
performed according to the manufacturer´s instructions. 
Quantification of the number of cells incorporated BrdU was carrying 
out by flow cytometry (Cytomics FC500, Beckman Coulter).  
3.6. Apoptosis quantification and caspase-3 activity 
To analyze apoptosis, cells were labelled with R-
phycoerythrin-conjugated annexin-V in combination with the cell- 
cell-impermeant DNA fluorophore 7-AAD (both Molecular Probes). 
The assay was performed according to the manufacturer´s protocol. 
Cells were analyzed by Flow Cytometry (Cytomics FC500, Beckman 
Coulter).  
Caspase-3 activity was measured by a colorimetric assay kit 
(Sigma-Aldrich Quimica, Spain), using acetyl-DEVD-p-nitroanilide 
(Ac-DEVD-pNA) as a substrate. Then, the samples were read at 405 
nm by the formation of the colorimetric product, p-nitroaniline, and 
the activity was calculated according to the to the manufacturer´s 
instructions. 
 
3.7. RNA isolation, Reverse-Transcription PCR and 
Quantification of mRNA levels 
 RNA was isolated from undifferentiated, differentiating and 
differentiated cells at established times, using Tri Reagent (Sigma) 
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according to manufacturer’s instructions. The amount of purified 
RNA was estimated on nanodrop by measure of absorbance at 260 nm 
and its purity was assessed by the ratio 260/280 nm. RNA integrity 
was examined by agarose gel electrophoresis. RNA (1 µg) of each 
sample was reverse transcribed using Transcriptor First Strand cDNA 
Synthesis kit (Roche). Diluted cDNA (dilution 1/10) was amplified 
with a rapid thermal cycler (LightCycler Instrument, Roche 
Diagnostics) in 20 or 10 μL of LightCycler 480 SYBR Green I Master 
(Roche) and 0.5 μM of each oligonucleotide. The sequences of both 
the forward and reverse primers used in this study are shown in Table 
1. Each sample was quantified for each gene by triplicates in at least 
five independent cultures. In parallel, we analyzed the mRNA levels 
of the human housekeeping GAPDH as an internal control for 
normalization. To ensure that treatments didn’t alter GAPDH mRNA 
levels, the Ct values were compared between groups. No significant 
differences were found in GAPDH levels. 
 
 
Table 1. Sequence of primers used for RT-PCR and length of fragments  
 
Ge
ne 
       Forward primer       Reverse primer Product 
(bp) 
αFETO
PROTE
IN 
5’-AGCTTGGTGGTGGATGAAAC-3’ 5’-CCCTCTTCAGCAAAGCAGAC -3’ 
248 
GFAP 5’-TCATCGCTCAGGAGGTCCTT-3’ 5’-CTGTTGCCAGAGATGGAGGTT-3’ 383 
GAPD
H 
5’- AGCCACATCGCTCAGACACC- 3’ 5’- GTACTCAGCGCCAGCATCG-3’ 301 
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CB 1 5’-GAACCCCATCATCTATGCTCTG-3’ 5’- CAATCTTGACCGTGCTCTTG-3’ 194 
CB 2 5’- ATGGGCATGTTCTCTGGAAG -3’ 
5’- GAACCAACAGATGAGGAGCA -
3’ 
152 
FAAH 5’- GGAGACCAAACAGAGCCTTG-3’ 5’- GGTCCACGAAATCACCTTTG-3’ 154 
NAPE-
PLD 
5’- GGTGAGTTAGCTTTGAGGTGTG-
3’ 
5’- 
GCCAGACGAGTGGAAATAGAAC-
3’ 
246 
MAGL 5’- CTTGCGTTGAGTTCCTTCTC-3’ 5’- TTTGCCTTCCTCTCACCTTC-3’ 151 
MAP 2 5’-TTTTCCCTCATGGGAGTCAG-3’ 
5’-GACATGCAAGGCACAGAAGA-
3’ 
251 
NANO
G 
5’-CAAAGGCAAACAACCCACTT-3’ 5’-CTGGATGTTCTGGGTCTGGT-3’ 426 
NESTI
N 
5’-AACAGCGACGGAGGTCTCTA-3’ 5’-TTCTCTTGTCCCGCAGACTT-3’ 220 
PAX-6 
5’-
AACAGACACAGCCCTCACAAACA-3’ 
5’-CGGGAACTTGAACTGGAACTGAC-3’ 275 
Β-
TUBU
LIN III 
5’-ACCTCAACCACCTGGTATCG-3’ 5’-GGGATCCACTCCACGAAGTA-3’ 449 
CASP
ASE 3 
5’-GAACCACTATGAAGCTACCTCAA-
3’ 
5´-CACAGATGCCTAAGTTCTTCCAC-3’ 291 
SOX 2 5’-GGGAAATGGGAGGGGTGCAAAAGAGG 5’-TTGCGTGAGTGTGGATGGGATTGGTG 150 
CD 133 5’-TTGGAGTGCAGCTAACATGAG 5’-GGGAATGCCTACATCTGGAA 300 
OLIG 1 5’- TGCCAGTTAAATTCGGCTACTACC 5’-TTGCATCCAGTGTTCCCGATTTAC 390 
 
 
 
PCR amplicons were confirmed to be specific by size and melting 
curve analysis. The real-time monitoring of the PCR reaction, the 
precise quantification of the products in the exponential phase of the 
amplification and the melting curve analysis were performed with the 
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LightCycler 480 quantification software, as recommended by the 
manufacturer. Table 1 illustrated the sequences of the primers used 
and the   length of the fragments. 
 
3.8. Immunofluorescence 
 Cells were growing in laminin and poly-L-ornitin-coated glass 
coverslips (12 mm) in 4- well plates were used for the 
immunofluorescence studies. Cells were fixed with paraformaldehyde 
(4% in PBS) for 20 min, permeabilized with 0.25% Triton X-100 for 5 
min, as previously described (Rubert et al., 2006).  After washing with 
PBS, the fixed cells were incubated with 5% BSA in PBS for 30 min 
to block nonspecific antibody binding. Cells were then incubated with 
the primary antibodies: mouse anti-GFAP (Sigma), rabbit anti-nestin 
(Chemicon), rabbit anti-MAP2 (Chemicon), mouse anti-TUJ1 
(Abcam), rabbit anti-GABA-A (Chemicon. Co), anti-glutamate 
(Sigma-Aldrich.), anti-PAX6 (Abcam); anti-C2B5 (Sigma-Aldrich, 
Spain). All antibody incubations were performed in 0.1% Triton-1% 
BSA in PBS for 1 h at room temperature. Appropriate secondary 
antibodies (Jackson Immunoresearch, Mississauga, Ontario, Canada) 
conjugated with fluorophores were used thereafter. For actin filaments 
staining, cells were incubated for 45 min with phaloidin-TRITC 
(Sigma-Aldrich, Spain), as previously described (Minambres et al., 
2006). Nuclei were stained incubating in DNA-binding dye Hoechst 
33342 (Molecular Probes, Leiden, The Netherlands) at a dilution 
1/40,000 in PBS for 10 minutes at room temperature. Micrographs 
were digitally recorded with a Leica microscope (Wetzlar, Germany). 
40                                              Material and Methods 
 
 
To quantify intensity of signal, a minimum of ten fields were taken of 
at least three different cultures. Immunoreactivity was determined 
with Metamorph-Offline software (Universal Imaging, Downingtown, 
TA).  
 
3.9. Stimulation of NPs with LPS  
         For these experiments neural progenitors at day 15 of their 
proliferation stage were used. Cells were rinsed and incubated in 
serum-free medium with for 18 h, and then NPs were stimulated or 
treated with 50 ng/ml LPS for 10 or 30 min.  After the treatment, cells 
were scraped, centrifuged at 3600 rpm for 5 minutes, in a 0.5 ml 
Eppendorf tubes. Supernatant was eliminated and the precipitate was 
resuspended with RIPA Buffer was (80 μl- 100 μl). The cell 
suspension was incubated in ice for 30 minutes, centrifuged at 13 000 
rpm for of 15 minutes. The supernatant was used for protein and 
kinases determination by Western blotting.  
 
3.10. Nuclear fraction isolation from NPs 
 Nuclear fraction from NPs was isolated as previously 
described (Ishida et al., 2002). Briefly, NPs were treated with h LPS 
(50 ng/ml) for 30 min. Then, cells were washed with PBS, scraped 
and centrifugated a 350g for 10 min. The pellet was resuspended in 
Solution 1 + 0.2% NP-40 and left 5 minutes on ice. Then, cell 
suspension was centrifuged at 1000g for 10 minutes, and supernatant 
containing the cytoplasmic fraction was removed.  
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Pellet was the suspended in 1ml of Solution 2 and centrifuged 
at 1000g for 10 minutes. The pellet was resuspended in Solution 3 and 
incubated on ice for 20-30 minutes. The next step was centrifugation 
at 10000g for 10 minutes, supernatant was removed and NUCLEAR 
fraction was obtained. The nucler fraction was used to assess 
NFkB.p65 by Western blotting analysis. 
 
SOLUTIONS: 
Solution 1: 
- Na2HPO4  5mM pH 7.4 
- NaCl 50mM 
- Sucrose 150mM 
- KCl 5mM 
- DTT 2mM 
- MgCl2 1mM 
- CaCl2   0.5mM 
- PMSF 0.1mM 
Solution 2: 
- 30% (w/v) sucrose 
- Tris-HCl 2.5mM pH 7.4 
- NaCl 10 mM 
 
Solution3: 
- Tris-HCl 2.5mM pH 7.4 
- NaCl 300mM 
- Triton X-100 0.5% 
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3.11.Cell lysis 
 
For the cell lysis was used RIPA Buffer with additional components: 
 
RIPA Buffer 
Tris-HCl pH 7.5—20mM       0.5M 
NaCl—350mM                       5M 
EDTA—1mM                         0.5M 
Triton—1%                             100% 
Na pyrophosphate—2.5mM     
Na3VO4—1mM 
NaF—1mM 
MilliQ Water 
 
Additional components 
Roche mini complete (1 tablet for 10 ml)    1 tablet in 1 ml of water 
PMSF 0.1M and RIPA Buffer 
 
3.12. Mice and alcohol treatments 
Female C57BL/6 wild-type mice (Harlan Ibérica) weighing 
18-20 gr were used.  All animals were kept under controlled light and 
dark conditions (12/12h), temperature (23ºC) and humidity (60%). For 
chronic ethanol treatment, 7-week old female C57BL/6 were housed 
(3 animals/cage) and maintained with water containing 10% (v/v) 
ethanol and a solid diet ad libitum for 2 months. During this period, 
the daily food and liquid intake was 3.26±0.91 gr and 3.49±0.5 ml of 
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10% ethanol in water, respectively. Ethanol concentration in the 
drinking water was progressively increased for the first two weeks to 
finally reach 12.8±1.2 gr/kg/bw over 2 months. Blood ethanol levels 
achieved in ethanol-treated mice were 125±20 mg/dl (range 87-140 
mg/dl).  
After mating, the control and alcohol-fed dams were placed in 
separate cages during the gestation and lactation. 
All animal experiments were carried out in accordance with 
the guidelines approved by the European Communities Council 
Directive (86/609/ECC) and by Spanish R.D. 1201/2005. All the 
experimental procedures were approved by the Ethical Committee of 
Animal Experimentation. 
 
3.13. Brain tissue extraction and homogenization 
Cerebral cortex of control and ethanol-exposed pups, at 
different postnatal ages, was used. Brain tissue was homogenized with 
a Potter in a modified RIPA buffer (see below) (1:50), incubated on 
ice for 30 min and centrifuged at 13.000 rpm for 15 minutes at 4 
degrees. Supernatant was used for protein determination and for 
Western blotting analysis.  
 
RIPA Buffer (modified) 
Chemicals        Cf                 Stock 
NP-40              1%                  10% 
Tris pH8           20mM             1M 
NaCl                130mM           5M 
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NaF                 10mM            0.5M 
DTT                 1mM             1M 
Aprotinin          10μgr/ml         1 mg/ml 
Leupeptine       40μM              5mg/ml 
Na3VO4           1mM              100 mM 
PMSF               1 mM             100 mM 
Water                up to 1 ml of entire solution 
 
3.14. Bradford Method for protein quantification 
       To assess protein determination in the brain and cells extracts, we 
first performed a standard curve using BSA (bovine serum albumin). 
Each sample was measured in duplicate with using 2 and 4 μl  of the 
sample + 800 μl of miliQ Water + 200 μl Biorad Reagent, using in 
parallel BSA standard samples. After 10 min at room temperature, the 
optical density was measured at 595 nm in a spectrophophotometer. 
 
3.15. Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and Western blot analysis 
 
 For SDS-PAGE, the different samples were mixed with a 
buffer containing Tris 350mM pH6.8, glicerol 30%  (v/v), β-
mercaptoetanol 30% (v/v), SDS 100gr/l and bromophenol blue 200 
mg/l.  Each sample was boiled at 100º C for 5 minutes. Equal amount 
of cells or brain lysate of each sample was loaded onto sodium 
dodecyl sulphate-polyacrylamide gels (SDS-PAGE). For 
electrophoresis Mini Protein system (BioRad) was used. The gels 
Material and Methods                                                                          45 
 
 
were prepared in two parts: Stacking gel 5% which serves to 
concentrate the proteins to the same line and pass to the next phase at 
the same time- to the Resolving gel (7-10% pore) to separate the 
proteins according to their size and modifications. The electrophoresis 
was performed in electropforesis buffer containing Trizma base 
30gr/l, glycine: 144 gr/l and SDS 10gr/l; in the phase of Stacking gel 
at 100V and in the other part at 80V.  Molecular weight markers were 
run in parallel (Molecular Weight Rainbow, Amersham). 
 
Gels were then blotted onto polyvinylidene fluoride membrane. The 
transference was performed in transfer buffer which contained (Tris 
25 mM pH 8.3, glycine 192 mM and 20% of methanol). The 
transference was performed for 1 hour at room temperature at 100 V 
or at 30V overnight at 4º C (cold room). 
Membranes were blocked with 5% dried milk in Tris-buffered saline 
containing 0.1% Tween-20 (TBS-T) for 1 hour at room temperature 
on an orbital shaker. The membranes were briefly rinsed for 2 or 3 
times with 0.1% TBS-T and then incubated for 2 hour at room 
temperature or overnight at 4 ºC ( see table 2) 
Then membranes were incubated with the appropriate 
secondary antibody, and proteins were visualized with either enhanced 
chemiluminescence system (ECL Plus, Amersham Pharmacia 
Biotech., Madrid, Spain) or alkaline phosphatase conjugate (Sigma-
Aldrich). Band densities were quantified using the AlphaImager 2200 
software (Alpha Innotech Corporation, San Leandro, USA). 
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Membrane stripping 
In most cases, membranes were striped and incubated with the 
GAPDH as a loading control. 
Stripping buffer: 
4ml        Glycine 1M pH 2.5 
800μl     10% SDS 
15.2 ml    MiliQ Water 
And after in non-fat dry milk. The next steps were the same. 
Table 2: Primary antibodies used 
 
Antibody Dilution Made in kDa Location CIA 
TLR4 1:500 Rabbit 80 Freeze Abcam 
pERK 1:250 Mouse 42-44 Fridge Sta.Cruz 
MyD88 1:300 Rabbit 35 Fridge ProSci 
RhoE 1:1000 Mouse 30 Freezer Apstate 
NFkB-p65 1:50 Rabbit 65 Fridge Sta.Cruz 
GAPDH 1:3000 Mouse 37 Fridge Chemicon 
ERK 1:250 Rabbit 42-44 Fridge Sta.Cruz 
IRAK 1:100 Rabbit 80 Fridge Sta.Cruz 
P38 1:250 Rabbit 38 Fridge Sta.Cruz 
Lamin A/C 1:1000 Rabbit 70 Freezer Cell Signaling 
TLR2 1:200 Rabbit 90 Freeze IMGENEX 
 
Stacking gel (5%) 
            GEL 1 (4 ml) 
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H2O (ml) 2.92 
Acril/Bis (ml) 0.5 
Tris pH 6,8 (ml) 0.5 
SDS 10% (μl) 40 
PSA 10% (μl) 40 
TEMED (μl) 4 
 
 
Resolving gel 
PERCENTAGE 6% 7,5% 10% 12% 
H2O (ml) 5.8 5.425 4.8 4.3 
Acril/Bis (ml) 1.5 1.875 2.5 3 
Tris pH 8,8 (ml) 2.5 2.5 2.5 2.5 
SDS 10% (μl) 100 100 100 100 
PSA 10% (μl) 60 60 60 60 
TEMED (μl) 7 7 7 7 
 
3.16. Statistical analyses 
Statistical analysis was assessed by one-way ANOVA. Following a 
significant F value, post-hoc analysis (Student – Newman - Keuls) 
was performed.  P < 0.05 was considered statistically significant. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
---------------------RESULTS--------------------- 
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Results 
4.1. Experimental approaches to establish the condition for human 
embryonic stem cells (hESC) growth and maintenance 
 
a) The use of different feeder cells  
  (a)          
 
    (b)                                                                                
Fig.1. Two different morphologies of the human embryonic stem cells 
H9 line on HFF (human foreskin feeder)(a) and STO (the mouse 
embryonic fibroblast cell line)(b) 
 
 Previous studies have demonstrated that mouse embryonic 
fibroblasts (MEF) can be used as a suitable layer to grow human 
embryonic stem cells (hESC) (Thomson, 1998). Therefore, in order to 
establish an appropriate feeder layer for growth hESC, H9, we used 
two types of fibroblasts: human foreskin fibroblast (HFF), STO or 
cells derived from mouse embryos and mouse embryonic fibroblasts 
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or MEF. As shown in Figure1, the morphology of the H9 colonies was 
differed depending on the type of feeder layer used. Thus, the cell 
colonies grown on HFF display a flat morphology (with sharp edges) 
(Fig1. a), while spherical colonies were found when H9 was grown on 
STO (Fig.1,b). These results suggest that the shape of the hESC 
colonies acquired in culture depends on the type of supporting cells 
where the cells were grown.   
  
 
 
 
Fig.2. Alkaline phosphatase assay for pluripotency (H9 colony on 
HFF) 
       
Under all the experimental conditions in which the different 
feeder layers were used, hESC colonies were cleaned mechanically 
(every second day) with an insulin needle. Then every 6-7 days, hESC 
colonies were mechanically cut into small pieces and passed to new 
gelatin feeder covered plates. An alternative procedure to pass the 
pieces of colonies was to use collagenase, dispase (enzymatically). 
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These results suggest that the shape of the hESC colonies acquired in 
culture depends on the type of supporting cells the cells actually were. 
        Most undifferentiated embryonic stem cells are characterized by 
high expression levels of stage-specific embryonic antigens (SSEA-1, 
3 and 4), tumour rejection antigens (TRA-1-60 and TRA-1-81), OCT-
4 and alkaline phosphatase, a marker of hESC pluripotency. Under our 
experimental conditions, hESC-H9 expressed alkaline phosphatase, 
which means that our cells were pluripotent (see Fig. 2). 
       
b)  The use of different media to culture hESCs under feeder-free 
conditions. 
We also assessed the appropriate condition for growing hESC 
under feeder-free conditions and using different media. One of the 
experimental approaches used was to grow cells in a conditioned 
medium from H9 growing on MEF since this medium contains all the 
essential factors needed for self-renewal and cells were also 
maintained in an undifferentiated state. However, one disadvantage of 
MEF (mouse embryonic fibroblasts) is that it contains animal-based 
ingredients, which may increase the risk of cross-transfer pathogens 
(Fig.3a). Therefore, in order to avoid this risk factor, we grew hESC 
on Matrigel (BD MatrigelTM) under feeder-free conditions and cells 
were maintained in a serum-free medium containing high levels of 
bFGF, TGF β and GABA, pipecolic acid, lithium chloride 
(mTeSRTM1) (Fig.3b). These trophic factors are crucial for the 
maintenance of human embryonic stem cells, as reported elsewhere 
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(Ludwig et al, 2006). However, H9 cells proliferate more efficiently 
when grown in the fibroblast-conditioned medium than with the 
commercial mTeSRTM1 medium. 
 
           (a)            
           (b)           
 
Fig.3. Feeder-free conditions in two different media. H9 were grown 
on MatrigelTM in Conditioned Medium (CM) (a) and in the 
commercially available mTeSR1 medium (b). 
 
 Regarding the use of feeder-free conditions, one disadvantage 
was that the colonies formed were smaller than when H9 were grown 
on feeder layers. Therefore, in the experiments used in this study, we 
employed human fibroblast feeders to grow the hESC-H9. 
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4.2. Characterization of hESC-Derived Neural Progenitors Cultures 
To prepare neural stem cells progenitors (hNP) from hESCs 
and undifferentiated hESCs (the H9 line, Fig.1), we allowed to form 
embryoid bodies (EBs). Specifically, hESCs-H9 were grown on HFF 
for 6-7 days, and when cells acquired the appropriate morphology and 
size, they were transferred to a low-attachment plate.  
 
 
Fig. 4. Scheme of neural differentiation from hESC H9 towards 
mature neurons and glia. a: The first scheme demonstrates the entire 
process from hESC to differentiated cells. b: The second scheme 
demonstrates the phase on polyornithine/laminin-covered plates with 
three conditions (Ct, 25mM and 50mM).  
 
 
 The colonies formed started to acquire three-dimensional 
aggregates, called embryoid bodies (EBs), which contain the three 
embryonic layers (ectoderm, mesoderm and endoderm). The process 
took approximately six days to achieve mature EBs. For the first two 
days, floating colonies were grown in ES medium, then two days in 
Day 0 
Neural progenitors Mature neurons and 
astrocytes 
Control 
+ 25mM 
  EtOH 
+ 50 mM 
 EtOH 
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the Neural Induction Medium (NIM) and the ES medium, and finally 
for two days in NIM (see scheme, Fig. 4). 
 
For neural induction, EBs were scattered and transferred to 
adherent conditions on Matrigel-coated plates and allowed to 
differentiate into neurosphere-like structures known as neural rosettes. 
The morphology of rosettes corresponds to tightly connected, radially 
spread columnar epithelial cells. Rosettes are neural tube-like 
structures that contain high levels of neuroprogenitors cells (Zhang et 
al, 2001; Perrier et al, 2004) (Figs. 5 and 6).  
                   
            Fig.5. Summary pictures of  Neural Differentiation from hESC. 
 For neural induction, EBs were scattered and transferred to 
adherent conditions on Matrigel-coated plates and allowed to 
differentiate into neurosphere-like structures known as neural rosettes. 
The morphology of rosettes corresponds to radially spreaded columnar 
epithelial cells tightly connected. After the dissociation of rosettes and 
54                                                                   Results 
 
 
counting by a cell counter using Trypan Blue, cells were plated under 
adherent conditions and were cultured in a serum-free proliferating 
medium (PM) containing bFGF (20ng/μl). The number of cells was 
optimised from 250,000 to 350,000 for 2 ml plates, and approximately 
to 80,000 cells for the 4-well plates that were used in the 
experiment.Under these conditions, neural progenitors proliferate and 
form spherical aggregates or clusters (Fig. 5). On days 7-8, aggregates 
were dissociated; cells were counted again, and were split and re-
plated with fresh media. This process was repeated up to 3 times 
(one/week). For three weeks of hNPs proliferation, cells initially 
adopted rosette-like structures (Fig. 5) and then, as the cell number 
increased, they formed aggregates or clusters displaying a radial glia 
array with long filament projections emerging from the central area to 
the peripheral area (Fig. 5). By day 21, clusters were dissociated; cells 
were cultured in differentiating medium (containing BDNF, 10ng/μl) 
for 15 days. Under these conditions, cells were allowed to differentiate 
into mature neurons, astrocytes and oligodendrocytes as a final stage 
of our differentiation process. 
 This protocol was simulated (in vitro) in the first trimester of 
human gestation, and proved a very important tool to investigate 
different genes and protein expression, as well as the neuroteratogenic 
effect of ethanol, which is one of the most abused neurotoxic agents. 
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     (a)                 
      (b)              
      (c)                   
Fig.6. Embryoid bodies (EBs, three-dimensional aggregates representing 
three germ layers (a). Neural progenitors spreading out of the forming 
clusters and appearance of neural rosettes in the Matrigel stage, which is 
not typical for the phase (b). Neural progenitors with the typical cluster 
shape and with neural extensions, and the cell confluent stage phase (c). 
 
Figure 6 shows different stages of the NPs-expressing GFP 
during proliferation. The pictures depict the NPs aggregates of 
immature neuronal cells, as well as the areas where cells spread out. 
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This figure (a) illustrates the diverse shape and size of EBs. In our 
experiments, we took EBs of a similar size and shape. This figure also 
illustrates (b) rosettes and clumps, which are not typical for this stage, 
although we also detected late rosettes with a lumen, as well as 
neurons with long extensions separated from attached EBs. 
A                                         B 
      
                          
 
Fig.7. Neural progenitors cells 18 days after growing in NPM medium with 
bFGF on polyornithine/laminin-coated plates. Cells are with the GFP 
construct. 
 
      Furthermore, Figure 7 also illustrates a typical clump, which 
appeared during the proliferating period with long extensions around 
it. This type of cell distribution is typical after NPs platting on the 
polyornithine/laminin-coated plates. The right picture depicts the 
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confluent stage of NPs, prepared to be split to other new 
polyornithine/laminin-coated plates (4-well or 6-well). The passage of 
NPs usually occurred every 6-7 days after plating. Then cells were 
prepared to a new exposure to bFGF or in differentiating medium with 
BDNF (Ahmed S, 1995).  
 
4.3. Differential expression of several genes during NPs 
proliferation and differentiation.  
 
During the differentiation process from human embryonic stem 
cells, various genes and signaling pathways were involved. We 
therefore investigated the gene expression of the different markers of 
the three embryonic layers (ectoderm, mesoderm and endoderm), as 
well as the markers of neural progenitors. 
An RT-PCR analysis (Figs. 8, 9) indicated that during the first 
week of culture, cells expressed Nanog (an hESC-specific marker of 
pluripotency), PAX-6 (a neuroectodermal marker, which is also a 
marker of neural progenitors) and α-fetoprotein (an endodermic 
marker). However, the expression of these genes markedly decreased 
or disappeared (e.g., -fetoprotein) during the 3 weeks of 
proliferation, revealing a neuroectodermal linage-like trend towards 
the most possible pure neural line, leading to mature neuron and glial 
cells (Figs. 8 and 9). Lack of expression of Brachyury confirmed no 
mesodermal contamination.  
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Fig. 8. The RT-PCR analysis of the gene expression NANOG, SOX2 of hNPs 
during their proliferation and differentiation in the presence or absence of 
ethanol (25 and 50mM . Data are  average ± SD. 
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Fig. 9. The RT-PCR analysis of gene expressions of AFP, PAX6 and CD133 
of hNPs during their proliferation and differentiation in the presence or 
absence of ethanol (25 and 50mM).  Data are average ± SD. 
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Fig. 10. The RT-PCR analysis of the gene expression of GFAP, MAP2, 
OLIG1, NESTIN, TUJ1 of hNPs, during the NPs proliferation and 
differentiation in the presence or absence of 25 and 50mM ethanol. . Data 
are average ± SD. 
 
 
Furthermore, the expression of the neural-related genes  
revealed that, while neural precursors nestin and TUJ-1 were high 
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during cell proliferation and then decreased during cell differentiation 
(Fig.10), the levels of MAP-2 and GFAP were undetectable or very 
low during cell proliferation, but markedly up-regulated into mature 
cells during cell differentiating (Fig.10).  
It is noteworthy that on day 14 of the proliferation stage, the 
levels of expression of nestin started to decrease, and this event 
parallels the up-regulation of the TUJ-1 expression, suggesting that 
neuronal precursors, including radial glia, are already transformed into 
neuronal precursor TUJ-1. These results indicate that under our 
experimental conditions, the NPs contained a relatively uniform 
population of forebrain progenitors, which can be differentiated from 
hESCs ,and that the temporal pattern of neurogenesis/gliogenesis from 
in vitro-produced human neural progenitors is preserved in our culture 
system.  
 
4.4. Ethanol affects hNPs proliferation and rosette formation 
  Our previous studies have demonstrated that in utero alcohol 
exposure impairs the cell proliferation and self-renewal capacity of rat 
neural stem cells (Rubert et al., 2006). Therefore, to evaluate whether 
human NPs were sensitive to alcohol effects, we added ethanol (25 or 
50 mM) to the medium and we assessed the potential actions of 
ethanol on hNPs during their proliferation and differentiation. One of 
the initial effects observed in ethanol-treated cells was a reduction in 
the size of the aggregates or clusters formed during cell proliferation 
(Fig.11). 
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Fig.11. Morphological alterations in NPs exposed to ethanol 
 Two treatments with 25mM and 50mM ethanol clearly 
demonstrate a reduction in cell number in relation to untreated cells. 
We observed that ethanol significantly reduces the number of cells 
during the proliferation phase (Fig.11) and disrupts central aggregates 
or radially concentrated cells.  
  
 
  
 
 
 
 
 
 
Fig.12. Number of cells in the control and ethanol- (25mM, 50mM) exposed 
cells. Data are average ± SD. 
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           Quantification of the number of hNPs in clusters demonstrates 
that ethanol dose-dependently reduces NPs, although the values were 
only statistical significant in the 50-mM treated cells (p < 0.01, Fig. 
12). 
 
4.5. Ethanol impairs human neuroprecursors survival  
 
       To investigate whether the reduction in the number of cells occurs 
by impairment in cell proliferation or by increased cell death, or by 
both, we first incorporated BrdU into the control and the ethanol-
treated cells.  
    
Fig. 13. Incorporation of BrdU and percentage of BrdU-positive cells at 
various stages of cell proliferation and differentiation in the control and in 
the alcohol-exposed (25 and 50 mM) cells. Data are average ± SD. 
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As expected, the percentage of incorporation of BrdU into the control 
NPs was higher during cell proliferation than during their 
differentiation (Fig. 13). The data in Figure 14 also reveal that ethanol 
treatment slightly reduced the incorporation of BrdU into hNPs, but 
this reduction was not statistically significant.  
 
Fig.14. Incorporation of BrdU and the percentage of BrdU-positive cells at 
various stages of cell proliferation and differentiation in the control and in 
the alcohol-exposed (25 and 50 mM) cells. Data are average ± SD. 
        
  We then analyzed the potential effects of ethanol on cell survival. 
For this purpose, cells were labeled with annexin V-PE, a marker of 
early apoptosis stages (Herault, 1999). In addition, and in order to 
distinguish necrotic cells from apoptotic cells, the annexin V analysis 
was performed simultaneously with a dye exclusion stain, such as 7-
amino-actinomycin D (7-AAD) (Herault, 1999; Lacoeur et al., 2002).   
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Fig.15. Percentage of death cells measured by the annexin assay (annexin 
positive cells) using R-phycoerytrin-conjugated annexin-V with cell-cell-
impermeant DNA fluorophore 7-AAD.Control and alcohol-exposed (25 and 
50mM) cells 
  
 
 
 
 
 
 
Fig.16.Temporal gene expression of Caspase-3 and Caspase-9 activity. 
Control and ethanol-exposed (25 and 50mM) cells 
 
 The flow cytometry analysis revealed that ethanol increased 
either the annexin+ population or the number of apoptotic cells 
(Fig.14). 
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 Moreover, the data in Figure 15 also reveal that while ethanol 
at 25 mM mainly increased the annexin V+ cells, at higher 
concentrations, e.g., 50 mM, ethanol also triggered necrotic cell death, 
as shown by the increasing population of annexin V and AAD + 
(Fig.15). To confirm these data, an increase in nuclear fragmentation 
from alcohol-treated cells was also observed with the 
immunofluorescence studies. According to these data, 25 mM ethanol 
significantly up-regulated caspase 3 activity, while higher ethanol 
concentrations, e.g., 50 mM, increased caspase 3 only in the cell 
differentiation stage (days 28 and 35). Likewise, ethanol also up-
regulated the mRNA levels of caspase 3 (Fig.16). 
 
4.6. Ethanol affects the expression of human neurogenic 
progenitors and impairs their differentiation into mature neural 
cells 
In order to gain additional insight into the potential actions of 
ethanol on hNPs during their in vitro proliferation and differentiation, 
we determined the expression levels of different gene markers. The 
data in Figures 8 and 9 illustrate that ethanol, at 25 mM and 50 mM, 
significantly increased the gene expression of AFP on day 7 of the 
proliferating stage, suggesting that ethanol affects loss of endodermal 
markers towards neural precursors. Furthermore, while the levels of 
transcription factors Nanog and PAX6 were down-regulated during 
hNPs differentiation, ethanol treatment abolished the down-regulation 
of Nanog and significantly increased the gene expression of PAX-6 
(Fig. 9). An RT-PCR analysis also demonstrates that while ethanol 
Results                                                                       67 
 
 
treatment significantly increased the expression levels of neural 
precursor Nestin, it reduced the up-regulation of both MAP-2 (a 
marker of mature neurons) and GFAP (an astrocytes marker), as 
observed during cell differentiation in the control hNPs. These results 
suggest that ethanol impairs the transformation of hESC into NPs and 
mature neural cells, causing an up-regulation of neural precursors 
(e.g., nestin) and decreasing the expression of genes of mature 
neurons and astrocytes.  
 
4.7. Morphological characterisation of the human neural precursor  
culture and its differentiation: effects of ethanol. 
 
An immunocytochemical analysis of hNPs colonies 
demonstrates that on days 7 to 14 after plating, the majority of neural 
progenitors form rosette–like pattern structures (Figs. 5 and 6) and 
then spherical clusters (Figs. 5 and 6), which were mainly composed 
of a central population of tightly packed small cells forming round 
structures, along with a flat epithelial-like peripheral population which 
migrated outwards from the cluster (Figs. 5 and 6). The double 
immunostaining performed for nestin and TUJ1 reveals that by day 7, 
about 76% of the epithelial-like peripheral and central cells were 
positive for nestin (76 ± 15%), while 34 ± 12% of the cells with a 
unipolar and bipolar morphology on the cell periphery expressed TUJ-
1.(Fig.17D).  
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Fig.17. Immunocuytochemical characterisation of hNPs.  
At this stage, ~ 80% of cells expressed Pax-6 (Fig. 17A). On 
day 14, the nestin+ cells showing a RG morphology decreased (43 ± 
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10%), while the TUJ1+ cells displaying dendritic arborizations and 
markedly increased (58 ± 13%) (Fig.17E).  
  
On days 14 and 21, 41 ± 17% of cells expressed nestin, while 
60 ± 14% were Tuj1+. We were unable to detect glial fibrillary acidic 
protein (GFAP) and MAP-2 positive cells during cell proliferation. 
These findings agree with the data obtained by RT-PCT (Fig.10). The 
immunocytochemical analysis also revealed that during cell 
differentiation (day 28), the cells which were initially organised as 
aggregates, displayed more complex dendritic arborizations and that  
they were stained with nestin and MAP-2, as well as TUJ-1 and MAP-
2 (Fig. 17). Some TUJ-1-positive neurons were also immunoreactive 
for GABA-A+ (Figure 11-I) and glutamate (Figure 17). During 
prolonged maintenance, and specifically on day 35, about 15 ± 9% of 
cells were immunoreactive for the astroglial marker glial fibrillary 
acidic protein (GFAP) (Figure 5K). On day 42, the percentage of 
astrocytes (GFAP+) was 20 ± 12% and appeared at the bottom of the 
MAP-2 positive neurons (Fig. 17).  
  
Ethanol exposure markedly affected the morphology profile of 
NPs cells. Thus, Figure 11 shows that ethanol altered the morphology 
of the rosette-like structures (Fig.18) and lowered the number nestin- 
and TUJ-1-positive cells, forming spherical aggregates during the 
proliferation stage (days 7-21) (Fig. 18).  
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Fig.18. Immunocuytochemical characterisation of hESC – derived neural  
precursors. Effects of ethanol (25 and 50mM). 
 However, although ethanol significantly reduced the number 
of cells, the percentage of the cells expressing nestin and Tuj1 at the 
different time points of proliferation was similar to that of controls. 
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Nevertheless, although the number of cells was significantly 
reduced by ethanol, the percentage of cells expressing nestin and Tuj1 
at the different time points of proliferation was similar to that of 
controls.  Furthermore, a striking effect of ethanol was seen, which 
consisted in an alteration in cell morphology and cytoskeleton 
changes. 
Cells immunoreactive for Nestin (type VI, Intermediate 
filament) and Tuj1 (Class III,  Tubulin Isotype) displayed shorter 
processes and abnormal filaments (Fig.18 D, E, H, K). In addition, 
while actin filaments were organised into stress fibres as bundles 
running throughout the cytoplasm in the control cells, ethanol 
exposure markedly disrupted actin organisation by changing stress 
fibres into actin rings on the cell periphery (Fig.18 F). These effects 
were more marked in the NPs exposed to 50 mM than those exposed 
to 25mM. Furthermore, during cell differentiation, ethanol reduced the 
percentage of cells expressing MAP-2. Thus, while 21 ± 10% of the 
control cells expressed MAP-2, only 15 ± 7% of the alcohol-exposed 
(50 mM) cells were MAP-2+ on day 28 of the culture. Similarly, 
immunoreactive GABA-A and glutamate neurons were also slightly 
reduced in the alcohol-treated NPs.  Likewise, whereas 20 ± 12 % of 
the control cells were immunoreactive for GFAP on day 42, in the 
ethanol- (25 and 50mM) treated cells, only 5% were GFAP+.  
Taken together, our findings demonstrate that ethanol not only 
affects the proliferation of NP cells, but markedly reduces their 
differentiation of NPs into mature neurons and astrocytes. The results 
also indicate the disruption of several cytoskeletal proteins by ethanol 
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and suggest that changes in these cytoskeletal proteins might underlie 
the alterations in cell shape and the functions of the NPs exposed to 
ethanol (Luo, 2002).  
 
4.8. Expression of new genes in hESCs and human 
neuroprogenitors. 
 
On the basis that neural human NPs cells derive from hESCs 
and given an in vitro protocol for neural induction, the proliferation 
and differentiation used in the present study can mirror early forebrain 
neural development. Thus, we evaluated the expression of new genes, 
a situation which has only been described in rodents during neural 
differentiation. 
 
           4.8.1: Expression of the endocannabinoid system in hNPs  
 
           Cannabinoid receptors are part of the endocannabinoid system, 
which is comprised of cannabinoid receptors, endogenous 
cannabinoids (endocannabinoids), and the enzymes that synthesise 
and degrade endocannabinoids. Endocannabinoids are involved in a 
wide variety of physiological and pathophysiological processes. 
Recent studies with rodents have demonstrated the presence of a 
functional endocannabinoid system in neural progenitor cells that 
participate in the regulation of cell proliferation and differentiation 
(Aguado et al., 2005, 2006, 2008). We therefore wondered whether 
the EC system was also expressed in human NPs. 
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Fig.19.A quantitative PCR (qPCR) analysis of CB2, FAAH and NAPLD 
receptors during NPs proliferation and differentiation.  Data are average ± 
SD of five  different cultures(#p<0.5,##p<0.01,###p<0.001). 
 
  
           For this purpose, the expression of the transcripts of the EC 
receptors (CB1 and CB2), along with the enzymes involved in EC 
synthesis (NAPE-PLD) and degradation (FAAH), were assessed. As 
Figure 19 illustrates, CB2 decreased from day 0 to day 7, and was 
then maintained with a very low expression during cell proliferation 
and differentiation. No significant changes were noted in the CB1 
expression (data not shown). Conversely, a progressive increase in 
74                                                                   Results 
 
 
NAPE-PLD was observed throughout the culture time, which reached 
maximal levels during differentiation. The FAAH expression also 
significantly increased on day 35 when the maximal NAPE-PLD 
expression was observed. These results suggest that endocannabinoids 
are present during the early human neural development stage and may 
play a role during neural differentiation into neurons and astrocytes. 
Ethanol exposure did not significantly affect endocannbinoids during 
hNPs proliferation and differentiation (Fig.19) 
 
             4.8.2: TLRs expression in human embryonic stem cells and 
in hNPs during the proliferation and  differentiation stages    
 
 Toll- like receptors are transmembrane proteins, which were 
described for the first time in Drosofila melanogaster, which control 
the developmental process in dorso-ventral patterning (Valanne S., 
2001). Until recently, it was thought that TLRs were involved only in 
immune responses, but new findings suggest that TLRs signalling may 
influence multiple dynamic processes in the developing and adult 
central nervous system, including neurogenesis, axonal growth and 
structural plasticity.  
We therefore evaluated whether TLRs, particularly TLR4, 
were expressed in human ESCs and in hNPs during their 
differentiation to mature neural cells. The RT-PCR analysis 
demonstrates (Fig.20) a lack of the TLR4 gene expression in hESC-
H9. However, the expression of these receptors was detected in EBs, a 
structure containing the three germ layers (ectoderm, mesoderm and 
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hNPs during their proliferation and differentiation. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig.20. The quantitative PCR (qPCR) analysis of the TLR4 receptor 
during hNPs proliferation and differentiation control and after 25 and 
50mM ethanol exposure. Data are average ± SD of five different 
cultures (p<0.5). 
 
 
Thus, although we observed that TLR4 is expressed on D0 of 
hNPs differentiation (Fig. 20), a maximal expression was observed on 
D7 of NPs proliferation, decreasing thereafter during NPs 
differentiation ( D21-D35). 
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Fig.21. The Western blot analysis of TLR4 in hESC, EBs and NPs during 
their proliferation (D0-D14) and differentiation (D28-D35). The 
densitometric analysis of the protein levels of TLR4/GAPDH. Data are 
average ± SD of three different cultures (p<0.05). 
 
 
We also measured the effects of ethanol on the TLR4 mRNA 
expression. Although no significantly major changes were noted 
during NPs differentiation, ethanol significantly reduced the TLR4 
mRNA levels on D7 of NPs proliferation and also induced some 
changes on D20 and D25 of NPs differentiation (Fig. 20). 
We next assessed whether the protein expression of TLR4 was 
also detected in hESC-H9, EBs and hNPs. The Western blot analysis 
demonstrated that whereas TLR4 was not expressed in H9 cells, the 
Results                                                                       77 
 
 
levels of this protein were markedly expressed in both EBs and NPs 
(Fig. 21).   
     
        
                                                                              TLR2 
 GAPDH 
Fig.22. The TLR2 protein expression in hESCs and hNPs during NPs   
proliferation and differentiation. The blots were densitometrically 
quantified and the results were expressed as levels of the 
TLR2/GAPDH ratio. Data are average ± SD of three different 
cultures (#p<0.05, ##p<0.01). 
 
 
One notable finding was that the levels of TLR4 increased 
during NPs proliferation and they peaked on day 14 of NPs 
proliferation, decreasing thereafter during the differentiation stage 
(D28-D35) (Figure 21). These results agree with the data obtained by 
RT-PCR on the gene expression of TLR4 in both hESCs and NPs.  
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To further evaluate the expression of TLRs in hESCs and NPs, we 
assessed the protein expression of TLR2, another important receptor 
in the innate immune system. The Western blot analysis demonstrated 
a very high expression of TLR2 in hESC-H9 (Fig. 22).   
 
 
 
Fig.23. The TLR4 signalling pathway. Activation of TLR4 by its 
ligands, LPS, leads to downstream signalling molecules (MyD88, 
Traf-6, IRAKs) to form complex I, which activates complex II 
formation (Traf-6, IRAKs, TAB-1, -2 and TAK-1) and culminates in 
the activation of MAPKs and transcriptional factors (NF-kappaB and 
AP-1) to regulates the expression of the target genes in the immune 
response. Ethanol can activate TLR4 signalling 
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Fig.24. Stimulation of NPs with LPS increases the TLR4 expression 
and  triggers the activation of IRAK and ERK upon 10 min of 
stimulation, and of NFkB upon 30 min of LPS treatment. 
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  The expression of TLR2 was also detected in both EBs and 
NPs during their proliferation and differentiation (Fig. 22). Low levels 
of NPs were observed on D0, then TLR2 increased on days 14 and 21 
of NPs proliferation, to then decrease on D28 of NPs differentiation 
The expression of the TLRs in NPs raises the question as to 
whether these receptors are functional. As mentioned above, Toll-like 
receptors (TLRs) belong to a family of pattern-recognition receptors 
in the innate immune system. These receptors enable an innate 
immune recognition of endogenous and exogenous prototypic ligands, 
and an orchestrated innate and adaptive immune response to infection, 
inflammation and tissue injury. TLRs response involves the 
recruitment and activation of complex intracellular signaling cascades, 
which culminate with the induction of cytokines and other 
inflammatory mediators. Among these receptors, TLR4 was 
stimulated by endotoxin LPS, leading to the activation of different 
kinases, including IRAK (interleukin receptor 1 activated kinase) to 
trigger a fast downstream stimulation of nuclear factor-κB (NF-κB) 
and the induction of the genes encoding inflammation-associated 
molecules and cytokines, as well as the activation of mitogen-
activated protein kinases (MAPK) and AP-1 nuclear factor (see Fig 
23). 
   Therefore, in order to assess whether the expression of TLR4 
in hNPs was a functional receptor, hNPs on day 15 of proliferation 
were stimulated with lipopolysaccharide (LPS, 50 ng/μl) for 10 and 30 
min. Activation of IRAK, ERK (signal-regulated kinase) and NFkB 
was assessed. Figure 22 shows that LPS stimulation triggered the 
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phosphorylation of IRAK and ERK at 10 min, and also activated the 
nuclear translocation of NFkB at 30 min upon stimulation (Fig. 27). 
These results suggest the functional role of TLR4 in hNPs. 
  
4.9. Developmental changes of TLR4 and TLR2 protein expressions 
during mice brain ontogen: effects of ethanol exposure.   
 In order to gain further insights into TLR4 and TLR2 during 
brain development and since hNPs provide us with only some 
information about the expression of TLRs during early embryogenesis 
we evaluated the expression of TLR2 and TLR4 in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.25. Changes in the TLR4 protein expression in mice cerebral 
cortices of foetuses and pups during the different stages of brain 
development. Gestation days 15 and 18 (-D15, -D18), and pups on 
days 0, 14, 21 and 30 of the postnatal period. The relative expression 
of TLR4 in the cortices of adult animals is also shown. Data are 
average ± SD of three or more different animals (p<0.05). 
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Fig.26. Changes in TLR4 in the cerebral cortices of the control and ethanol-
exposed pups during postnatal development. Data are average ± SD of three 
or more different animals (p<0.05). 
 
mice brains during prenatal and postnatal brain development. In 
addition, to assess the potential action of ethanol on TLRs during 
development, we also used fetuses and pups of alcohol-fed mice 
during gestation and lactation. 
 
Results                                                                       83 
 
 
 Fig.27. Changes in the TLR2 (TLR2/GAPDH) protein expression in 
cerebral cortices during mice brain ontogeny. Gestation days 15 and 18 
(D15-, D18-) or postnatal period days 0. 7, 21 and 30. Data are average ± 
SD of three or more different animals (p<0.05). 
       
Analysis of the TLR4 expression demonstrates that whereas 
TLR4 was highly expressed during embryonic development (foetal 
days 15 and 18), its expression lowered in the cerebral cortices of 
newborn mice to then increase during the postnatal period (Fig. 25). 
 Interestingly, alcohol exposure increased TLR4 levels during 
the early postnatal stages (days 0 and 7) and then slightly lowered the 
TLR4 levels on postnatal days 21 and 30 (Figure 26). These results 
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suggest that alcohol either up-regulates TLR4 during the neonatal 
period or delays the initial maturation of the cerebral cortex. 
   
 
 
 
 
 
 
                              
                                    D0     D7     D14    D21   D30 
 
 
 
 
 
 
 
Fig.28. Effects of ethanol exposure on TLR2  in  developing mice. Data are 
average ± SD of three or more different animals (p<0.05). 
       
  Concerning TLR2, the expression of this receptor was 
relatively high and remained constant during the prenatal and 
postnatal periods. Indeed, the levels during the prenatal and postnatal 
periods did not show statistically significant changes, except for a 
significantly high level which was noted on day 14 after birth, which 
GAPDH 
TLR2 
GAPDH 
  
TLR2 
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slightly increased on postnatal day 21 (Fig. 27). Unlike the effects of 
ethanol on increasing the TLR4 expression only during the neonatal 
period, ethanol exposure up-regulated the TLR2 levels only at the end 
of the postnatal period, on days 21 and 30 (Figure 28). Different 
functions of these receptors during postnatal development might 
explain these differential effects.  
 TLR2 in female mice treated with 60 % of ethanol shows a 
different pattern in receptor expression demonstrating increasing level 
in relative expression of the receptor (Fig.31). The lowest level of the 
TLR2 we noticed at day of birth and during development was TLR2 
reached the highest expression (30 days old mice). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-------------------DISCUSSION------------------ 
 
  
86                                                             Discussion 
 
 
Discussion 
 
5.1.Human Neuroprogenitors (hNPs) derived from human 
embryonic stem cells (hESC) 
 
 Derivation of human neuroprogenitors (hNPs) from human 
embryonic stem cells (hESC) is of value in the study of early human 
neurogenesis and in the creation of unlimited sources of donor cells 
for neural transplantation therapy. In this work, we have characterised 
and established an in vitro culture protocol that allows differentiation 
of hESC towards human neural precursors (hNPs). The protocol 
employed has been modified by a previous culture protocol (Nat et al, 
2006). In our study, we were able to differentiate hNPs into radial glia 
(RG), neurons, astrocytes and oligodendrocytes (Carpenter et al, 2001; 
Kiersted et al, 2005), as demonstrated by the gene expression of 
different neural cell markers and by immunocytochemistry analysis.  
 We initially tested different conditions for growing hESC. In 
particular, hESC were grown in three different feeder conditions: 
human foreskin fibroblasts (HFF), mouse fibroblasts (STO) and under 
feeder-free conditions on Matrigel. We demonstrated that the hESC 
growing on human or STO exhibit typical markers of pluripotency 
(SSEA-3, SSEA-4, TRA-1-60 and TRA1-81) (Park et al, 2003), 
normal karyotype, Oct4 and alkaline phosphatise (AP), as 
demonstrated in previous studies (Park et al, 2003). However, when 
hESC were grown under feeder-free conditions and maintained on 
Matrigel, as a protein supporting the cells in mTESR1 (Ludwig et al, 
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2006; Ludwig et al, 2006), hESC grew less efficiently than in 
fibroblast feeders. In fact, it is known that fibroblasts support hESC 
and that they confer them growth factors, adhesion molecules and 
cellular matrix production. These conditions represent a hESC in vitro 
niche. More recently, hESC culturing moves towards biomaterial 
supported feeder-free conditions, which are also free of foreign 
antigens and proteins that could have important applications in clinical 
and biotechnological studies. For example, they use a polyamide-
based 3D nanofibrillar porous matrix, which enhances self-renewal 
and the proliferation of hESC in comparison with culture dishes. A 
synthetic polymer matrix has also been described as a cell culture 
substrate, which could provide a completely defined 
microenvironment for hESC (Zhang  et al., 2011). One disadvantage 
of feeder-free conditions is that embryonic stem cells give thinner 
colonies, although this approach offers the advantage of the animal 
component being absent, which is more suitable and precise for any 
analysis type and potential clinical use (Ludwig et al, 2006).  
 Human ESC can be maintained without forming monolayer 
culture systems since they are propagated as floating aggregates. 
Under such conditions, hESC form aggregates and embryonic bodies 
(EBs), they express pluripotency markers and they can differentiate 
towards the three germ layers in vivo and in vitro (Steiner  et al, 2010; 
Stojkovic et al, 2004). This procedure is the most widely used method 
for inducing hESC. Usually, EBs aggregates are exposed to mitogens 
to be then dissociated and reattached to specific subtracts in order to 
provoke proliferation and differentiation to specific lineages.  
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 For the neural linage, several methods have been developed to 
avoid endodermal and ectodermal contamination. For example, Ying 
and collaborators (2003) identified neural precursor populations and 
eliminated non-neural populations. However, the most widespread 
protocol for neural differentiation is the spontaneous formation of 
three-dimensional aggregates EBs. EBs recapitulate the processes 
occurring in vitro in early embryogenesis, with the appearance of 
lineage-specific regions similar to formation in early embryos. After 
4-6 days in suspension, the EBs from hESC start to differentiate 
towards epiblast-like cells on the surface of the one EB representing 
primitive endoderm cells. Culturing EBs for several days results in 
differentiation into ectoderm, mesoderm end endoderm. This pattern 
could be directly translated to events occurring in the early human 
embryo. EBs could be directed to any kind of cell type by using 
different types of factors and morphogens. For neural cell 
differentiation, EBs aggregates are treated in early stages with specific 
morphogens to allow the differentiation of EBs into the ectoderm 
(Zhong-Wei Do and Su-Chun Zhang, 2004) For example, Shin et al.  
(2006) used hESC growing on mouse embryonic fibroblasts (MEF) 
for the first 7 days. Then they incubated hESC with neural induction 
medium containing a mix of morphogens for 7 days. Finally, they 
propagated the rosettes in proliferation medium and obtained hNPs 
(Shin et al, 2006).By making full use of previous studies, in our 
protocol, EBs were cultured on a neural induction medium, then EBs 
were transferred to adherent conditions on Matrigel-coated plates to 
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allow differentiation into neurosphere-like structures known as neural 
rosettes. 
 
 
Figure D-1. Clustering analysis of differentially expressed genes. A) 
Frequency distribution of the expression levels of the genes belonging to the 
five defined groups. B) Dendogram of the relationship of the expression of 
the genes belonging to each group (with biological replicates represented by 
letters A, B, C and D) and an examples of the genes present in the five 
defined groups. C) Schematic representation of the successive cellular states 
occurring along the path to neural differentiation  (Abranches E, 2009). 
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Neural rosettes structures are neural tube-like structures that 
contain high levels of neuroprogenitors cells (Zhang et al, 2001; 
Perrier et al., 2004) and expressed specific gene types (Fig. D-1). By 
this procedure, we efficiently obtained relatively pure hNPs in the 
absence of endodermal and mesodermal contamination, as 
demonstrated by the expression of α-fetoprotein (an endodermic 
marker) and Brachyury (a mesodermal marker). 
 In our cultures of hNPs, in order to control proliferation and 
differentiation, we used serum-free neural proliferation medium 
(NPM) containing Fibroblast Growth Factor (bFGF), which represents 
the main proliferating factor for the neural progenitors pool. This 
factor directs forebrain specification in the absence of other extrinsic 
factors (Bartlett et al, 1998; Mason I, 2007). Furthermore for cell 
maturation, we utilised serum-free neural differentiation medium 
(NDM) with the key differentiating factor BDNF (Brain Derived 
Growth Factor) (Ahmed S, 1995). Neuroprogenitors cells were 
maintained in the Neurobasal medium in which the osmolarity and 
concentration of several amino acids lowered. In order to maintain 
NPs, B27, containing RA (retinoic acid), was added to the medium. 
The other often used supplement that is added to Neurobasal medium 
is N2, which has a subset of B27 that includes insulin, which could act 
as a ligand of insulin-like growth factor receptors to induce the 
differentiation of hESC and the proliferation of the differentiation 
cells. It has been demonstrated that the survival and proliferation of 
neural progenitors is more efficient in B27-supplemented medium 
than in a medium with N2.  
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5.2.hNPC as a model to study early brain development 
 One of the major challenges in many studies is to obtain 
homogenous specific cell population and to renew neural progenitor 
cell populations capable of differentiating into specific neuronal or 
glial cell types. A critical point in the differentiation of hESC into NP 
cells is to maintain a self-renewing pool of NPs. When exposed to the 
correct environmental signalling cues, NP cells can follow a unique, 
robust temporal cell differentiation process to form numerous 
phenotypes (Dhara and Stice, 2008). Another yet unexplored 
advantage of the derivation of hESCs into NPs is that they can also 
prove to be a tool to elucidate the mechanisms underlying early 
human neural and brain development. 
In the present work, we used an in vitro culture that efficiently 
directs both the differentiation of hESC towards NPs and the 
generation of radial glia, neurons and astrocytes in a temporal pattern, 
which is capable of reproducing early stages of human brain 
development. The culture protocol maintains progenitors with 
forebrain specifications in the absence of extrinsic factor, and in the 
presence of FGF2 for NPs proliferation (Bartlett et al, 1998) and 
BDNF for their differentiation (Ahmed  et al, 1995).  
 Developing neural systems is a highly complex process that is 
controlled by complex signalling events which regulate the formation 
of the neural plate and neural tube. The embryonic neural tube is 
composed of a pseudostratified layer of neuroepithelial cells with 
clear apico-basal polarity. Rostro-caudal patterning processes  involve 
WNT (Wingless), FGF (Fibroblast Growth Factor), BMP (Bone 
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Morphogenic Protein) and RA (Ratinoic Acid) pathways. The final 
results of the interaction among these pathways are the formation of 
major segments of the central nervous system (CNS): forebrain, 
midbrain, hindbrain and spinal cord. Dorso-ventral patterning is 
controlled by two opposing signals: BMP and SHH (Sonic hedgehog) 
(Harland R, 2000; Dhara and Stice, 2008; Wilson and Stice, 2006). 
The cells located in different positions in the dorso-ventral and rostro-
caudal directions respond to different and position-specific 
morphogens.  
 Although our culture system has its limitations, it mostly 
reproduces early stages of human brain development. Indeed, 
neurulation is the first process during organogenesis and it begins 
from hESCs during early embryonic development events (Schoenwolf 
and Smith, 2000; Colas and Schoenwolf, 2001, Hornstein and 
Benvenisty, 2004). Furthermore, neural rosettes represent the in vitro 
analogue of neural tube formation after 2 weeks of hESC neural 
differentiation (Zhang et al, 2001). This period temporally correlates 
with the formation of the neural groove by 18 days in vivo and its 
subsequent rostro-caudal delineation by day 20 (O´Rahilly and 
Muller, 1994). Therefore, this stage is approximately the equivalent to 
the third week of human gestation if we consider that hESC are 
derived from 1-week-old embryos. 
  Regarding the neurogenesis process, recent evidence in 
developing human embryos has shown that the earliest born neurons 
are observed within the forebrain by days 31-35 (Bystron, 2006) and 
that these neurons precede local cortical neurogenesis. During 
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embryonic development, neural tube cells produce various types of 
neurons and glial cells, which will populate the CNS. The 
phenotypically diverse cells will be organised into different structural 
and functional units to form different specific synaptic contacts. This 
process generates neuronal circuits which are responsible for different 
simple and complex behaviours (McConnell, 1995). Our in vitro 
culture of human neural progenitors (hNPs) deriving from hESC 
coincide with the above findings. We found that rosette formation 
took place on days 15-17. Then in the presence of FGF2, which is 
involved in NPs proliferation and maintenance and generally in the 
stabilisation of neural identity (Carpenter et al 2001, Zhang 2004), 
epithelial cells, radial glia (RG) and immature neurons (TUI-1+) were 
observed during the maximal proliferation of hNP (days 18-39 of 
hESC or days 1-21 of hNPs proliferation) and postmitotic neurons 
(days 50-53, or day 35 in the differentiating medium including BDNF) 
which mirrors the early neural development phase of human embryos. 
In addition, quantitative PCR and immunocytochemical analyses 
reveal a temporal decrease in the expressions of the mesodermal 
marker (Brachyury), the endodermal marker (AFP) and the 
ectodermal marker (PAX6) in parallel with the up-regulation of neural 
progenitor markers, such as TUJ1 and Nestin, during the hNPs 
proliferation stage. A drop in the expression of the pluripotency 
markers Nanog and Sox2, which are crucial for the maintenance of 
hESC in an undifferentiated state (Thomson et al, 1998), was also 
noted during hNPs proliferation. The gene expression of Sox2, 
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together with c-MYc, KLF4 and Oct4, induce pluripotency in iPSC 
from somatic stem cells (Takashi and Yamanaka, 2006). 
        Our results further evidence that during their differentiation, 
hNPs are capable of giving rise to neurons, astrocytes and 
oligodendrocytes, as revealed by the up-regulation of the protein and 
gene expression of MAP-2, GABA and glutamatergic neurons, as well 
as the markers of glial cells GFAP (an astrocytes marker) and A2B5 
(an early oligodendrocytes marker). These results indicate that under 
our experimental conditions, hESCs-derived neural progenitors can 
reproduce the processes occurring in early nervous system 
development, and can be used as a tool to study both the molecular 
and cellular mechanisms during early forebrain development. In many 
CNS regions, including various layered structures, common 
progenitors produce both neurons and glial cells. Research into the 
developing cerebral cortex has suggested that neurons, astrocytes and 
oligodendrocytes derive from largely separated lineages (McConnell, 
1995). However NPs possess both a neurogenic and gliogenic 
potential, which means that the progenitor cells in rosette cultures 
could be converted into early neuron-producing or glia-producing 
cells (Abranches  et al, 2009). 
 The nervous system comprises different regions and 
derivation-specific neural progenitors. Those cells with a particular 
regional identity have a given function in the forming brain with a 
specific identity and phenotype. Forebrain-specific NPs appear first 
and express homeodomain-specific factors OTX1, OTX2, and BF1 
Forse 1, the recently described marker (Elkabetz et al, 2008). The cells 
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positive to these markers have been maintained in the presence of 
FGF2 (Zhang et al, 2006). Midbrain cells deriving from NPs are of 
much interest for therapeutic use in Parkinson’s disease. Markers for 
midbrain-specific neurons include TH, RAX, NURR1, PTX, 
LMX1a/b, PAX2 and EN. The main growth factors responsible for 
midbrain differentiation are FGF8 and FGF2 (Perrier et al, 2004). 
Finally, published data indicate that along the anterior-posterior axis, 
hindbrain formation is specified by the expression of HOX genes and 
by the influence of FGF2, SHH and Retinoic Acid (RA). The dorso-
ventral region is regulated with SHH (the ventral area) and BMPs (the 
dorsal area) and retinoic acid (RA) regulates the caudalisation process. 
By considering all these facts, researchers have successfully 
developed protocols for specific cell types (Li et al, 2005, 2008; Shin 
et al, 2005). 
 
 
5.3. TLRs and endocannabinoids during neural 
development 
 
 TLRs in hNPs and during mice brain ontogeny 
        Toll-like receptors (TLRs) were described for the first time in the 
Drosophila, and were seen to play a major role in dorso-ventral 
polarity, synaptogenesis and in axon guidance during the 
embryogenesis of the fruit fly embryo (Anderson et al, 1985; Halfon 
et al., 1995; Rose et al., 1997). However, recent findings suggest that 
mammalian TLRs also play developmental roles during 
embryogenesis (Okun et al, 2011), and that they might also perform 
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physiological functions during development (Okun et al, 2011). TLRs 
are mainly expressed in the immune system. However, some non-
immune cells, such as glial cells and neurons, also express these 
receptors. Yet the functional role of neuronal TLRs still remains 
uncertain (Okun et al, 2011). New roles of TLRs involve their 
participation in neuronal plasticity and in myelin sparing after spinal 
cord injuries or brain damage (Kigerl KA et al, 2006, Babcock AA et 
al, 2006, Kim D et al, 2007).  
  On the bases of the potential role of TLRs during brain 
development, we explored the possibility that TLR4 and TLR2 can be 
expressed in both hESC and hNPs. We demonstrate for the first time 
that although TLR4 is not expressed in hESC H9, the gene and protein 
expression of TLR4 are detected in EBs, structures containing the 
three germ layers (ectoderm, mesoderm and endoderm). We also 
reveal that the levels of TLR4, protein and gene expression increase 
during hNPs proliferation, with a maximal expression on D7 (mRNA) 
or D14 (protein), which lower thereafter during NPs differentiation 
(D21-D35). Conversely, protein expression TLR2 is high in hESC-H9 
and decreases in EBs. Furthermore during hNPs proliferation, TLR2 
increases on days 14 and 21, but decreases during NPs differentiation. 
These results indicate that TLR4 and TLR2 are expressed to NPs 
during not only hESC differentiation, but also during NPs 
proliferation and differentiation, suggesting a potential physiological 
role of these receptors during early stages of human CNS 
development. 
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 Recent studies in mice have demonstrated that TLRs play a 
role during the proliferation and differentiation of neural progenitor 
cells (NPCs). For example, deficiency of TLR3 increases the 
proliferation of the NPCs in the subventricular zone (SVZ) (Lathia  et 
al, 2008; Okun E et al, 2010), while deficiency of TLR4, MyD88 or 
TRIF enhances the proliferation of retinal progenitor cells (RPCs) in 
mice neonates (Shechter  et al, 2008) and in adult NPCs (Lathia JD et 
al, 2008). Accordingly, activation of TLR2, TLR3 or TLR4 inhibits 
the proliferation of SVZ-derived embryonic NPCs (Lathia  et al, 2008; 
Okun et al, 2010; Rolls A et al. 2007) (Fig. 2).  
Studies conducted  in mice also indicate that TLRs modulate 
adult hippocampal neurogenesis since TLR2 and TLR4 influence self-
renewal and the cell-fate decision in adult NSCs in culture (Rolls A, 
2007). TLR2 deficiency changes the level of the differentiation 
patterns of neural progenitors. This influence diminishes the number 
of neurons expressing early neuronal markers Tuj1 and increase 
differentiation into the cells with a glial phenotype, such as GFAP+ 
cells (Okun et al, 2011). These studies also demonstrate that the 
activation of TLRs in NPCs triggers MyD88 and NFkB signalling 
(Fig. 2). Our results with hNPs also indicate that the activation of 
TLR4 with LPS is capable of inducing downstream signalling as ERK 
phosphorylation and NFkB activation, suggesting that functional 
TLR4 signalling also occurs in hNPs. 
Using the cerebral cortex of mice during the prenatal and 
postnatal stages, our results further demonstrate that the expression of 
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TLR4 is high on day 15 of the foetal (F15) stage, but then lowers at 
the end of gestation to increase again during postnatal development 
 
 
Fig. 2 (A) Deficiency of TLR3, but not of TLR2, increases the proliferation of SVZ-
derived embryonic NPCs. Deficiency of TLR4, MyD88 or TRIF increases the 
proliferation of RPCs in neonates. Deficiency of TLR4, MyD88 or TRIF, but not of 
TLR2 or TLR3, increases the proliferation of DG-derived adult NPCs. (B)  
Activation of TLR2 by Pam3CSK4, TLR3 by PolyI:C or TLR4 by LPS inhibits the 
proliferation of SVZ-derived embryonic NPCs (middle panel). Activation of TLR4 
using LPS inhibits the proliferation of RPCs in neonates (right panel). Activation of 
TLR4 by LPS, and to a lesser extent activation of TLR3 with PolyI:C, but not of 
TLR2 using Pam3CSK4, inhibits DG-derived adult NPC proliferation . Activation of 
TLR2 and TLR4 with the above ligands also induces the release of TNF-α in these 
cells. This figure describes the work performed in mice (Okun et al., 2011). 
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 Furthermore, the expression of TLR4 at F15 and on postnatal 
day 30 is higher than in the adult cerebral cortex, suggesting a 
potential role of TL4 during both the proliferation and plasticity of the 
CNS (Okun et al, 2011).   
Regarding TLR2, previous studies have shown that TLR2 
activation has different effects on embryonic and adult neural 
progenitor cells. During the embryonic proliferation of neural 
progenitors, TLR2 exhibits a negative regulation, whereas it has no 
effect on the self-renewal potential in adult NPC (Okun et al, 2010; 
Rolls  et al, 2007; Covacu R et al, 2009).  
We noted that TLR2 is expressed during the early stages of 
mice cerebral cortex development, with a maximum level on postnatal 
day 14. In agreement with our results, a new study shows that TLR2 is 
expressed in the developing telencephalon from early embryonic 
stages and that it slightly increases during postnatal development 
(Okun et al., 2010). Infectious agent-related activation of TLR2 
inhibits NPC proliferation. Finally, the above findings suggest that if 
we consider the roles of TLR4 and TLR2 of NPC proliferation, 
differentiation, plasticity and their role in inflammation, it can be 
speculated that either the reduction or activation of these receptors 
during brain development, as in infection, ischaemia and 
inflammation, and alcohol exposure, can adversely affect brain 
development (Okun et al., 2010). In fact, our results demonstrate that 
ethanol exposure during the prenatal and postnatal periods increases 
the levels of TLR2 and TLR4, which might cause neuroinflammation 
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and brain damage (Alfonso-Loeches et al., 2010), thus contributing to 
the neuroteratogenic effects of ethanol.  
 
Endocannabinoids expression in hNPs 
          Endocannabinoids (EC), the endogenous counterparts of 
marijuana-derived cannabinoids, act as neuromodulators via 
presynaptic CB1 receptors, and also control neural cell death and 
survival. Studies conducted in the last 10 years have demonstrated the 
role of EC in the regulation of cell proliferation and differentiation of 
mice neural progenitor cells (Aguado et al., 2005, 2006, 2008). 
Indeed, mice NPs produce EC, and they express the CB1 receptor and 
endocannabinoid-inactivating enzyme fatty acid amide hydrolase 
(FAAH). CB1 receptor activation promotes cell proliferation and 
neurosphere generation, an action that is abrogated in CB1-deficient 
NPs. These results demonstrate that EC constitute a new group of 
signalling cues that regulate NP. At the same time, the CB2 receptor is 
also expressed, both in vitro and in vivo, in mice neural progenitors 
from late embryonic stages to the adult brain, and the pharmacological 
activation of the CB2 receptor in vitro promotes neural progenitor cell 
proliferation and neurosphere generation (Palazuelos  et al., 2006) 
(Molina-Holgado et al, 2007).  
          Although, we did not assess the role of EC in the proliferation 
and differentiation of hNPs, we demonstrate for the first time that 
hNPs express CB1, CB2 and the enzymes involved in EC synthesis 
(NAPE-PLD) and degradation (FAAH), suggesting that EC can 
modulate  hNPs proliferation and differentiation. In addition, although 
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EC play a modulatory role in alcohol dependence (Pava MJ and 
Woodward JJ, Alcohol 2012), the present study indicates that ethanol 
exposure during early embryogenesis has no significant effects on the 
expressions of  NAPE- PLD,  FAAH, CB1 or CB2 in hNPs.   
 
5.4. Effects of ethanol on human embryogenesis and 
neuroprogenitors. 
  
A large number of studies have evidenced the sensitivity of the 
developing brain to the damage caused by environmental chemicals 
and toxic compounds (Weiss, 2000). Ethanol is one of the most 
common and most important toxic substances to affect the developing 
foetal brain. Its consumption during pregnancy can produce a wide range 
of cognitive, behavioural and physical anomalies, and it is one of the 
leading preventable causes of birth defects and neurodevelopmental 
disorders (American Academy of Pediatricts, 2000). In the most severe 
cases, these anomalies make up a pattern of malformations termed foetal 
alcohol syndrome (FAS) (Jones et al, 1973). This syndrome is 
characterised by the following diagnostic criteria: 1) Maternal alcohol 
dependence or alcohol abuse during pregnancy, 2) Pre- and postnatal 
growth deficiency, 3) Central nervous system (CNS) dysfunctions, and 4) 
A particular pattern of facial features. However, CNS dysfunctions are 
the most distressing and permanent consequence of heavy or moderate 
alcohol consumption, and are manifested by long-term cognitive and 
behavioural deficits rather than physical anomalies. The incidence of 
these neurobehavioral dysfunctions is higher (5-19/1,000 births) than 
FAS (0.5-3/1,000 births) (Stratton et al., 1996).  
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 Accumulating clinical and experimental evidence also 
demonstrates the vulnerability of the developing CSN to effects of 
alcohol. Experimental evidence indicates that ethanol interferes with 
many ontogenetic phases of brain development. Therefore, the pattern of 
damage may explain the wide complex pattern of the behavioural and 
neurological abnormalities observed in human and animals exposed to 
alcohol at different times during brain development. These studies 
demonstrate that an important critical period for craniofacial 
malformations to appear in FAS is early embryogenesis. High levels of 
alcohol during the embryonic stage of gastrulation (7 days after 
fertilisation in mice) (Webster et al, 1983; Kotch and Sulik, 1992, Sulik, 
2005) and macaques exposed to ethanol on E19 or E20 (Astley et al, 
1999) can lead to the craniofacial abnormalities and brain abnormalities 
associated with FAS. Human studies have also shown that both binge 
drinking and chronic alcohol abuse during an early stage of human 
embryogenesis (corresponding to the third week of human gestation) is 
associated with a greater incidence of craniofacial defects and mental 
disabilities (Ernhart et al, 1987). The mechanisms of ethanol-induced 
malformations during human embryogenesis are unknown.   
 By using hNPs from hESC, we provide evidence that ethanol 
exposure, at concentrations that can be reached in the blood of 
alcoholics (Jones, 1992), induces cell death by apoptosis, as revealed 
by the increment in annexin + cells and caspase 3 activity, or necrosis 
at higher ethanol concentrations, such as 50 mM. We also observed 
that ethanol reduces hNP proliferation. In agreement with our human 
NPs results, some studies have demonstrated that ethanol inhibits mice 
neural progenitors proliferation by changing the expression of 
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cyclin/cyclin-dependent kinases, the p53 gene and DNA 
methyltransferase, these being the key genes involved in cell cycle 
check points (Hicks et al, 2010).  
Our previous studies have also shown that alcohol exposure 
during early rat embryogenesis in vivo (E12) reduces the proliferation 
of the radial glial progenitor pool, impairs the self-renewal capacity of 
thelencephalic multipotent progenitor cells and affects neurons and 
astrocytes generation (Rubert et al, 2006). In agreement with these 
results, our immunocytochemical and RT-PCR data reveal that in vitro 
ethanol exposure impairs the transformation of immature neuronal 
(Tuj1) and glial (Nestin) markers into mature neurons (e.g., MAP2) 
and astrocytes (e.g., GFAP). These results suggest that ethanol impairs 
the neuroprogenitors maturation process, as demonstrated in previous 
studies (Tateno et al, 2005, Rubert et al., 2006). Alterations in the 
methylation process or changes in the DNA demethylation of the 
genes participating in neural cell maturation (Valles et al., 1997) 
might involve impairing effects of ethanol on neural cell maturation. 
Recent studies have confirmed that alcohol delays the cellular DNA 
methylation programme and also retards embryonic growth. Since the 
direct inhibition of DNA methylation results in a similar retardation, it 
has been suggested that alcohol affects embryonic development 
through epigenetic mechanisms (Zhou FC et al, 2011).  
 The present findings also reveal that the derivations of NPs 
from hESCs towards neuroepithelial cells are affected by ethanol. 
Indeed, ethanol treatment alters the disappearance of AFP (an 
endodermal marker) during NPs proliferation, and it up-regulates 
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transcription factors Nanog and Pax-6 during their differentiation. 
Alterations in Pax6 induce defects in neural stem, while progenitor 
cells can cause forebrain abnormalities in humans and in experimental 
animals (see rev. Manuel and Price, 2005). Mice mutants of Pax6 
show defects in neural stem and progenitor cell proliferation, resulting 
in microcephaly and abnormal development in the subventricular zone 
(Warren et al, 1999; Quinn et al, 2007). Likewise, the overexpression 
of Pax6 also leads to the depletion of the stem cell pool by driving 
stem cells to a basal progenitor fate, leading to an overproduction of 
early-born, deep-layer cortical neurons, causing progenitors apoptosis 
(Manuel et al, 2007, Sansom et al, 2009) and resulting in forebrain 
abnormalities (Berger et al, 2007). If we consider the similarities of 
the later alteration and those induced by ethanol in NPs in culture, it 
can be postulated that the ethanol-induced up-regulation of PAX6 
possibly underlies some of the ethanol-induced defects noted in 
neuronal differentiation.  
 Notch signalling is also critical for the maintenance of the 
progenitor pool as it controls cell renewal, and regulates cell 
differentiation and cell fate determination. Our preliminary results 
indicate that the Notch expression decreases in the hNPs exposed to 
25mM ethanol at the initiation of astrogliogenesis (on day 28; data 
not shown). According to these findings, our previous results show 
that in utero ethanol exposure lowers the levels of activated Notch1 
and FGFR2, and decreases astrogliogenesis (Rubert et al., 2006). 
Since one of the prominent roles of Notch is to promote astrocytic 
fate (Gaiano and Fishell, 2002), an ethanol-induced decrease in Notch 
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activation at the onset of gliogenesis might account for the reduced 
GFAP expression during NPs differentiation. 
 Another important finding of the present study is that our 
results demonstrate that ethanol affects cell morphology and impairs 
several cytoskeletal proteins, including nestin, Tuj1 and actin. 
Interestingly, the actin reorganisation (e.g., loss of stress fibres and 
actin ring formation) observed in NPs is similar to that described in 
ethanol-exposed astrocytes (Minambres R et al., 2006, Guasch RM et 
al., 2003), and that these effects are associated with loss of focal 
adhesions, activation of the RhoA/ROCK-I/MLC pathway and 
apoptosis by anoikis in astrocytes (Miñambres et al, 2006). Therefore, 
ethanol-induced actin cytoskeletal reorganisation may not only 
underlie disruptions in cell morphology, synaptic formation and 
plasticity (Luo et al, 2002), but may also participate in ethanol-
induced NPs apoptosis. Deregulation of actin dynamics leads to 
cellular and cognitive anomalies in flies and mice (Sordela  and Aelst , 
2006). In vitro ethanol exposure has a negative impact on endocytosis, 
exocytosis and nucleocytoplasmic traffic in astrocytes, and alters 
endocytosis in cultured neurons. In astrocytes, these effects relate to 
changes in the organisation and/or function of microtubules and the 
actin cytoskeleton. In primary culture in rats, a difference in actin, 
tubulin and MAP2 distribution has been reported in control and 
ethanol-treated animals (Romero et al, 2010). 
In summary, by using hESC-derived NPs in culture, we demonstrate 
that ethanol exposure during early embryogenesis impairs NPs 
survival, affects the differentiation of NPs into neurons and astrocytes, 
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disrupts several cytoskeleton components and affects the expression of 
the different genes associated with neural differentiation.  
 
Summary,  
 We tested several conditions for human embryonic stem cells 
(hESC) by growing them on different feeder layers and under feeder-
free conditions in order to evaluate the best conditions to establish the 
derivatisation of hESC into human neuroprogenitors.  
By employing the in vitro culture that efficiently directs the 
differentiation of hESC towards NPs, we report the generation of 
radial glia, neurons and astrocytes in a temporal pattern, which is 
capable of reproducing early stages of human brain development.  
Neuroepithelial progenitors display both the morphological 
and functional characteristics of their embryonic counterparts and the 
proper timing of neurons and glia cells generation. 
Immunocytochemical and real-time (RT) polymerase chain reaction 
analyses reveal that cells appear as clusters during neuroepithelial cell 
proliferation and that the genes associated with the neuroectodermal 
(Pax-6) and the endodermic (α-fetoprotein) lineages decrease in 
parallel with the up-regulation of NPs genes (nestin and Tuj1), 
followed by their differentiation into neurons (MAP-2+, GABA+), 
oligodendrocytes [galactocerebroside (GalC+)] and astrocytes 
(GFAP+). We further demonstrate for the first time that human NPs 
express endocannabinoid receptors (CB1 and CB2) and the enzymes 
involved in endocannabinoids synthesis (NAPE-PLD) and degradation 
(FAAH). We also show for the first time that TL4 and TLR2 are 
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expressed in both hESC and hNPs. In parallel, we demonstrate that 
TLR4 and TLR2 are expressed during mice brain development 
because both receptors are expressed in both the prenatal and postnatal 
periods.  
Finally by using this in vitro culture model, we demonstrate 
that ethanol impairs NPs survival, affects the differentiation of NPs 
into neurons and astrocytes, disrupts the actin cytoskeleton, and 
affects the expression of different genes associated with neural 
differentiation such as affects the expression of different genes 
associated with neural differentiation, such as TLR4, TLR2, CB1, 
MAP2, GFAP. The results provide new insights into the effects of 
ethanol on human embryogenesis and neuroprogenitors, and offer an 
opportunity to delineate potential therapeutic strategies to restore early 
ethanol-induced brain damage.  
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Conclusions 
 
1- We establish an in vitro model for the generation of neural 
progenitors (NPs) from hESCs.  
 
2- Neuroepithelial progenitors display the morphological and 
functional characteristics of their embryonic counterparts, and the 
proper timing of neurons and glia cells generation.  
 
3- Immunocytochemical and RT-PCR analyses reveal that hESC 
appeared as clusters during neuroepithelial cell proliferation, and that 
the genes associated with the neuroectodermal and endodermal 
lineages decrease in parallel with the up-regulation of the genes of 
neural progenitors, followed by their differentiation into neurons 
oligodendrocytes and astrocytes. 
 
4- We demonstrate for the first time that human NPs express the 
endocannabinoid receptors (CB1, CB2) and the enzymes involved in 
endocannabinoids synthesis and degradation, as well as the TLR4 and 
TLR2 receptors. 
 
5- By using this in vitro model, we show that ethanol exposure:  
      - Impairs the derivation of hESCs towards neural cells, alters 
the disappearance of the endodermal marker AFP during NPs 
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proliferation and up-regulates the transcription factors Nanog, Sox2 
and Pax-6 during their differentiation.  
   - Impairs NPs survival, affects the differentiation of NPs into 
neurons and astrocytes, disrupts the actin cytoskeleton and affects the 
expression of different genes associated with neural differentiation.  
 
6-  The results provide new insights into the effects of ethanol on early 
human embryogenesis and offer an opportunity to delineate potential 
therapeutic strategies to restore early brain damage induced by 
ethanol.  
 
7-  Finally, the present study provides not only a new tool to elucidate 
the mechanisms underlying early human neural and brain 
development, but also offers the possibility to assess the 
neuroteratogenic actions of ethanol during early embryogenesis. 
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Resumen 
 
Diferenciación de células progenitoras neurales a partir de células 
humanas embrionarias (hESC) como modelo para el estudio de 
las fases iniciales en el desarrollo del cerebro en humanos y de los 
efectos neuroteratogénicos del etanol 
 
            Las células madre o troncales embrionarias humanas (human 
Embryonic Stem Cells, hESC) poseen dos características cruciales: 
capacidad ilimitada de proliferar y potencial de dar lugar a diferentes 
tipos celulares. Estas dos características las hacen idóneas como 
herramienta para evaluar su potencial para regenerar el tejido nervioso 
dañado, como ocurre en diferentes enfermedades neurodegenerativas. 
Al mismo tiempo, la diferenciación de las hESCs hacia 
neuroectodermo y células progenitoras neurales puede servir como un 
modelo in vitro para el investigar los procesos celulares y moleculares 
que ocurren durante las  primeras etapas del desarrollo del cerebro así 
como para analizar  la acción de ciertos neurotóxicos y teratógenos 
(ejem. El alcohol) que afectan el proceso de formación y desarrollo 
del cerebro durante de la embriogénesis temprana en humanos.  
Actualmente existen algunos trabajos que han diferenciado las 
hESC hacia células del tejido nervioso, pero existen pocos estudios 
que haya  abordado el estudio de las  primeras fases del desarrollo del 
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sistema nervioso central así como los las acciones del alcohol durante 
la fase temprana de la embriogénesis en humanos 
      
Objetivos 
            
Basados en los anteriores antecedentes, los objetivos de este trabajo 
han sido: 
    
 Desarrollar un protocolo in vitro de derivatización de 
células humanas neuroprogenitoras a partir de células 
multipotentes embrionarias humanas (hESC), que pueda 
reproducir las primeras fases del desarrollo del cerebro en 
humanos. 
 
 Caracterizar el cultivo in vitro de células hESC a 
neuroprogenitores (hNPs), evaluando la expresión de genes 
y proteínas durante la transformación de hESC a hNPs y 
durante la proliferación de NPs y su diferenciación a 
células maduras neurales (neuronas, astrocitos y 
oligodendrocitos). 
 
 Evaluar si ciertos sistemas y receptores, como el sistema 
endocanabinoide, incluyendo los receptores (CB1, CB2) y 
los enzimas que participan en su síntesis (NAPE-PLD) y 
degradación (FAAH), se expresan en los 
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neuroprogenotores humanos durante su proliferación y 
diferenciación. En roedores el sistema endocanabinoide 
juega un papel importante en la proliferación de los NPs 
 
 Investigar si los receptores TLR4 and TLR2 se expresan en 
hESC, hNPs y durante el desarrollo de cerebro en roedores.  
 
 Finalmente, investigar las acciones del etanol durante la 
diferenciación de hESC a hNPs así como durante la 
proliferación y diferenciación de los NPs humanos a 
células maduras neurales. Específicamente se evaluara el 
efecto del etanol sobre: 1) Expresión de genes y proteínas 
durante la derivatización de hESC a NPs, 2)  la 
proliferación de hNPs y supervivencia, 3) la expresión de 
genes y de proteínas así como las alteraciones morfológicas 
que puedan ocurrir durante la diferenciación de los hNPs a 
células neurales maduras, 4) expresión del sistema 
canabinoide y de  los TLR4 y TLR2 en hESC, hNPs y 
desarrollo de cerebro en ratones. 
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Metodos 
 
         Cultivos de hESC: El protocolo que se ha utilizado para 
establecer los NPs a partir de células embrionaria humanas (hESC) se 
representa en la Fig.4 de Resultados. Como hESC hemos utilizado la 
línea H9 (WiCell Inc., Madison WI).. Las células hESC se cultivaron 
en medio apropiado,  en un incubador  a  37C̊,  5% CO2,  y en 
condiciones de humedad. Se realizaron diferentes pases, de acuerdo 
con el tamaño de las colonias.  Para la obtención de cuerpos 
embrioides, la hESC se transfirieron a condiciones adherentes en una 
matriz de matrigel. Tras  6 días de cultivo en medio de inducción 
neural (NIM, que contenía el factor trófico, FGF2) se formaron  unas 
estructuras específicas en forma de “rosetas”, ricas en progenitores 
neurales. Estas estructuras se cortaron, se disgregaron,  y se 
siembraron a una concentración de 300,000 células en placas de 2 ml 
recubiertas con laminina/poliornitina. Las células se adhirieron y 
proliferaron en un medio que contenía FGF,  que denominamos medio 
de proliferación. Para la adición del etanol, tras sembrar las placas de 
cultivo, la células se incubaron toda la noche para permitir su adhesión 
a la placa, y posteriormente se añadio etanol al medio de cultivo a 2 
concentraciones, 25mM y 50 mM..Tras 21 días, el medio de de 
proliferación se sustituyo por medio de diferenciación que contenía 
BDNF. 
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Ensayos para medir proliferación,  Viabilidad celular y Caspasa 3 
 
Para evaluar proliferación se incorporo BrdU iy se siguió un 
protocolo establecido, siguiendo las instrucciones de un kit comercial  
(Roche, cat no. 11810740001). La cuantificación del número de 
células que incorporaron BrdU se evaluó mediante citometria de flujo 
(Cytomics FC500, Beckman Coulter).  
Para analizar la viabilidad celular y la apoptosis, las células se 
incubaron con R-phycoerythrin-conjugatdo annexina-V junto con el 
fluoroforo 7-AAD (Molecular Probes). Se evaluó la apoptosis y 
necrosis mediante citometria de flujo (Cytomics FC500, Beckman 
Coulter).  
La actividad Caspase-3 se midió mediante un procedimiento 
colorimétrico siguiendo las instrucciones de un ensayo comercial 
(Sigma-Aldrich Quimica, Spain) Este ensayo usa el sustrato acetyl-
DEVD-p-nitroanilide (Ac-DEVD-pNA). La intensidad del color y la 
formación del producto de la reacción, p-nitroaniline, se cuantifico 
mediante la lectura de las muestras a 405 nm en un espectrofotómetro, 
usando los controles correspondientes y una curva estándar.     
 
 
Inmunoelectrotransferencia 
La concentración de proteína, tanto en los lisados celulares como en 
cerebro , se cuantificó mediante el procedimiento de Bradford (Bio-
Rad, Hercules, CA, USA).  
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Para el análisis de proteínas concretas se utilizó la 
inmunoelectrotransferencia. Para ello se utilizaron geles de 1,5 mm de 
grosor con porcentajes de acrilamida (en el gel separador) entre el 7 y 
el 15% según el peso molecular de los fragmentos proteicos a resolver 
y adicionando dodecil sulfato sódico (SDS). Se mantuvo una relación 
acrilamida:bis-acrilamida de 30:0,8 en todos los casos. A las muestras 
obtenidas se les añadió tampón de carga 6x (350mM Tris pH 6.8, 30% 
glicerol, 30% mercaptoetanol, 100gr/L SDS, 200mg/L azul de 
bromofenol) y se hirvieron durante 5 min. Para la electroforesis se 
utilizó un sistema Mini Protean de Bio-Rad en tampón: 6gr/L de 
Trizma base, 2.88 gr/L de glicina y 20 gr/L de SDS.  
Las proteínas separadas por SDS-PAGE se transfirieron a membranas 
de PVDF (Immobilon Transfer Membrane, Millipore) en tampón 
3gr/L de Trizma base, 1.44 gr/L de glicina y un 20% de metanol, 
durante 1h a 100V.  
Las membranas se bloquearon durante 60 minutos en leche desnatada 
al 5% en TBS-Tween (TBS-T) 0.1% (Tris 20mM y NaCl 500mM pH 
7.5) y se incubaron durante toda la noche a 4ºC, en agitación, con los 
correspondientes anticuerpos primarios (ver Tabla 2, Material y 
Metodos). 
Las membranas se lavaron 3-4 veces con TBS-T 0.1% y se incubaron 
con los anticuerpos secundarios –anti IgG-conjugado con HRP (anti-
ratón peroxidasa, 1:1000, Santa Cruz; anti-conejo peroxidasa, 
1:20000,) durante 1 h a temperatura ambiente. Finalmente, las 
membranas se revelaron mediante quimioluminiscencia utilizando 
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ECL-Plus (Amersham) y se expusieron a films MXG de Kodak o 
Hyperfilm de Amersham. 
Para la cuantificación de la intensidad de las bandas, estas se 
capturaron digitalmente con un escáner (EPSON DX 4800) y la 
intensidad de las mismas se cuantificó por densitometría mediante el 
uso del programa Alpha-Ease FC, programa de análisis de imagen 
versión Alpha Imager 2200 (Alpha Innotech Corporation). La 
intensidad relativa de cada proteína individualmente se expresó como 
el ratio entre su intensidad y control de carga GAPDH, o su control 
respectivo 
 
Aislamiento de RNA y RT-PCR 
Para aislar ARN se utilizo el Tri-Reagent (Sigma), siguiendo 
las instrucciones de la casa comercial. La cantidad de ARN purificado 
se estimó midiendo la absorbancia a 260 nm y 280nm, y la pureza se 
estableció analizando la relación de la absorbancia 260/280 nm. La 
integridad del ARN se determinó mediante electroforesis en gel de 
agarosa. Para el análisis de RT-PCR, 1μg de ARN de cada muestra fue 
transcrita usando el kit Transcriptor First Strand cDNA Synthesis 
(Roche). El cDNA se diluyó (3μL) y amplificó en un termociclador 
(LightCycler Instrument; Roche Diagnostics) en 10μL de LightCycler 
480 SYBR Green I Master (Roche) y 0,5μM de cada oligonucleótido. 
La secuencia de cada uno de los cebadores o primers de los genes 
usados viene determinada en la Tabla 1(Material y Metodos). 
Los niveles ARNm de los genes SP1 o CypA se utilizó como 
control interno de normalización de los datos. Para asegurarnos de que 
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los tratamientos no alteraban los niveles de ARNm del control interno, 
los valores de Control se compararon entre los grupos experimentales. 
No se encontraron diferencias en los niveles de ARNm de SP1 o 
CypA. Para la cuantificación de los productos de la PCR, se analizó la 
fase exponencial de la amplificación de la curva de meelting y se 
cuantificó mediante el programa de LightCycler 480 quantification, 
siguiendo las recomendaciones de la casa comercial. 
 
Inmunofluorescencia 
 
Para este procedimiento laa celulas se cultivaron en cubres (12mm) 
recubiertos de  laminina y poli-lisina ien placas de 4 pocillos.. Las 
celulas se fijaron con paraformaldehido (4% in PBS) durante 20 min, 
se permeabilizaron con  0.25% Triton X-100 durante 5 min, como se 
describe en nuestros previos estudios (Rubert et al., 2006).  Tras un 
lavado con  PBS, las celulas fijadas  se incubaron con  5% BSA en 
PBS durante 30 min, para bloquear los lugares no especificos. Tras el 
bloqueo, las celulas se incubaron con los anticuerpos primarios: anti-
GFAP (Sigma), anti-nestin (Chemicon), anti-MAP2 (Chemicon), anti-
TUJ1 (Abcam), anti-GABA-A (Chemicon. Co), anti-glutamate 
(Sigma-Aldrich.), anti-PAX6 (Abcam); anti-C2B5 (Sigma-Aldrich, 
Spain). Todos los anticuerpos se incubaron con 0.1% Triton-1% BSA 
en  PBS durante  1 h a temperature ambiente. Tras lavar las celulas, 
esta se incubaron con los anticuerpos secundarios apropiados (Jackson 
Immunoresearch, Mississauga, Ontario, Canada) conjugados con 
diferentes fluoroforos. Los núcleos se tiñeron con el reactivo que se 
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une al ADN, Hoechst 33342 (Molecular Probes, Leiden, The 
Netherlands). Las fotos se tomaron con un microscopio  Leica 
(Wetzlar, Germany). Para cuantificar la intensidad de la fuorescencia, 
se tomaronal menos 10 campos por cultivo, y se usaron 3-4 cultivos. 
La inmunoreactividad se determino mediante el programa  
Metamorph-Offline software (Universal Imaging, Downingtown, TA).  
 
 
Conclusiones 
 
1- Hemos establecido un modelo in vitro en donde generamos  
progenitores neurales (NPs) a partir de células embrionarias 
humanas (hESC). 
  
2- Los progenitores neuroepiteliales y los  NPs humanos  
muestran características morfológicas y funcionales similares a 
las que se producen en el desarrollo embrionario, dando lugar 
a la generación de células gliales y neuronas a tiempos 
similares a los que se observan durante el desarrollo de 
cerebro. 
 
3- El análisis mediante inmunocitoquimica y RT-PCR muestra 
que la hESC forma agregados durante la fase de proliferación, 
disminuyendo durante esta fase la expresión de genes 
asociados al neuroendodermo y neuroectodermo e 
incrementando la expresión de genes asociados a progenitores 
neurales. Posteriormente, durante la diferenciación de los NPs 
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se produce la aparición de genes y proteínas marcadoras de 
neuronas, astrocitos y oligodendrocitos. 
 
4- Por primera vez demostramos que los NPs humanos  expresan 
los receptores de endocanabinoides (CB1 y CB2),  los enzimas 
que participan en la síntesis y en la degradación de los 
endocanabinoides, así como los receptores TLR4 y TLR2 
 
5- Mediante la utilización del modelo in vitro de hESC y de NPs 
demostramos que la exposición al etanol: 
 
- Altera la derivatización de hESC hacia células neurales, 
como lo demuestra la elevada expresión del marcador de 
endodermo AFP durante la proliferación y el aumento en 
los niveles de los factores de transcripción Nanog, Sox2 y 
Pax6 durante la diferenciación de los NPs. 
- Afecta la supervivencia de los NPs humanos, altera la  
diferenciación  de los NPs hacia células neurales  maduras 
(astrocitos, neuronas) afectando tanto la expresión de genes 
como de proteínas marcadoras de células neurales maduras 
y finalmente  cambia la morfología celular afectando  la 
estructura del citoesqueleto de actina. 
 
6- Los resultados de los efectos del etanol durante la 
embriogénesis temprana pueden proporcionar la posibilidad de 
desarrollar estrategias terapéuticas para restaurar los efectos 
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del etanol durante el inicio de la formación del sistema 
nervioso. 
7- Finalmente, el presente estudio describe un nuevo 
procedimiento para evaluar los mecanismos que subyacen al 
inicio del desarrollo del cerebro humano y también ofrecen la 
posibilidad de investigar los efectos neuroteratogenicos del 
etanol durante la embriogénesis temprana. 
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